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ATCC  American type culture collection  
 
Bglap bone γ-carboxylglutamic acid-containing protein, it 
is also known as osteocalcin 
 
β2M    beta 2 microglobulin 
 
°C    Celsius grades 
 
CD    cluster of differentiation 
 
cDNA    complementary deoxyribonucleic acid 
 
C-myc clone of v-myc myelocytomatosis viral oncogene 
homolog 
 
Col1    collagen type 1 gene 
 
DAPI    4', 6-diamidino-2-phenylindole 
 
DEPC water   diethylpyrocarbonate treated water  
 
FACS    fluorescence-activated cell sorting 
 
FITC    fluorescein isothiocyanate 
 




GATA6   GATA binding factor 6 
 
GFP    green fluorescence protein  
 
HPLF    human periodontal ligament fibroblasts 
 
HSPC    hematopoietic stem and progenitor cell 
 
hTERT   human telomerase reverse transcriptase 
 
Ibsp    integrin-binding sialoprotein 
 
IFN    interferon 
 
IgG    immunoglobulin G 
 
IL    interleukin 
 
i.p.    intraperitoneal 
 
Ki-67    kinase inhibitor 67 
 
Klf4    kruppel like factor 4 
 
LIF    leukemia inhibitory factor 
 
µg    microgram 
 
µl    microliter 
 
miRNA   microRNA 
 Abbreviations 
 VIII 
ml    milliliter  
 
MMPs    matrix metalloproteinases 
 
MSCs    mesenchymal stem cells 
 
ng    nanogram  
 
N-myc  neuroblastoma derived v-myc myelocyto-matosis 
viral related oncogene 
 
Oct4    octamer-binding transcription factor 4 
 
PCR    polymerase chain reaction 
 
PDGF platelet derived growth factor 
 
PDL    periodontal ligament 
 
PE    phycoerythrin 
 
PHA phytohemagglutinin A 
 
RANKL receptor activator of nuclear factor kappa-B ligand 
 
RLF/L-myc   rearranged L-myc fusion gene 
 
RNA    ribonucleic acid 
 
rpm    revolution per minute  
 Abbreviations 
 IX 
Runx2   runt related transcription factor 2 
 
SCP    single cell picked clones 
 
SD rats   Sprague Dawley rats 
 
Sox2    SRY (sex determining region Y)-box 2 
 
Spp1 secreted phosphoprotein 1, it is also known as 
osteopontin 
 
STAT3 signal transducer and activator of transcription 3 
 
Th cells   helper cells from the thymus 
 
TNF    tumor necrosis factor 




1.1 The Periodontium 
 
Periodontium is the attachment apparatus, or the teeth holding apparatus, that 
is responsible for the anchorage of the teeth in their correct position. The 
periodontium or the periodontal holding apparatus consists mainly of gingiva, 
periodontal ligament (PDL), cementum, and alveolar bone (Tan et al. 2009, 




Figure 1: The normal anatomy of the periodontium, taken from: 
http://www.erdent.com (2012). 




Periodontitis is a bacterial biofilm induced inflammatory disease that results in 
the destruction of the periodontal components including the destruction of the 
PDL, cementum, gingiva, and alveolar bone (Tan et al. 2009, Yanagita et al. 
2011, Park et al. 2011). 
 
 
Figure 2: Healthy and diseased periodontium, taken from: 
http://www.perio.org (2012). 
 
Periodontal disease results from the interactions of various etiologic factors 
including the subgingival microenvironment, social behavior, and genetic 
susceptibility of the individual host (Offenbacher 1996). Periodontitis is 
characterized by a dynamic nature of periods of remission and exacerbation. 
The cumulative destructive effect, associated with the exacerbation periods, 
results in the progressive destruction of the periodontal supporting structures 
and the subsequent loss of the teeth (Goodson et al. 1984, Haffajee et al. 
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1983). Although the fact that the periodontal pathogens play a great role in the 
initiation of the disease, it was found that the major cause of the soft and hard 
tissue destruction associated with periodontitis is the activation of the host-
immune inflammatory response to the periodontal pathogenic challenge 
(Hernandez et al. 2011). This explains the periodic exacerbation-remission 
destructive nature of the disease that is associated with the activity periods of 
the inflammatory response of the host- immune system. During the periods of 
activity a certain inflammatory response is initiated in the periodontal tissues, 
this response is characterized first by the proliferation of the 
polymorphonuclear cells as a first line of innate immunity, resulting in the 
overproduction of a certain hypersecretory macrophage phenotype that is 
responsible for the synthesis and the secretion of the IL-1β, IL-12, and TNF-α 
cytokines (Hernandez et al. 2011). The secretion of these inflammatory 
cytokines is associated with the release of some matrix metalloproteinases 
(MMPs) such as, MMP-8, MMP-9, and MMP-13 from a certain latent form of 
neutrophils (Hernandez Rios et al. 2009, Mantyla et al. 2006).  The MMPs are 
a group of proteinases that are involved in the host-immune inflammatory 
response including periodontitis (Folgueras et al. 2004). MMPs are able to 
degrade almost all the basement membrane and extracellular matrix 
components including type I collagen which is the main extracellular matrix 
component of soft and hard periodontal tissues (Golub et al. 1997). In cases 
of unresolved periodontal problem an adaptive inflammatory response is 
established that is characterized by the activation, proliferation, and 
differentiation of the naïve T-cells mainly to Th1 lymphocytes (responsible for 
the production of IL-2, IL-12, TNF-α, TNF-β, and IFN-γ cytokines), and Th2 
cells (responsible for the secretion of IL-4, IL-5, IL-6, IL-9, and IL-13 
cytokines). Recently,   a new subset of T- cells has been described by Vernal 
and Garcia-Sanz known as Th-17 cells. The Th-17 cells display great pro-
inflammatory and pro-resorptive activities through the secretion of IL-6, IL-21, 
IL-22, IL-23, IL-26, IL-17, and RANKL (Vernal et al. 2004, Vernal and Garcia-
Sanz 2008). The Th-17 cells may contribute to bone resorption either 
indirectly through the secretion of IL-6 and IL-17, which in turn increase the 
   1 Introduction 
 4 
inflammatory response and induce RANKL expression by the osteoblastic 
cells, or directly through the direct secretion of RANKL and IL-17 which are 
highly involved in the differentiation and activation of osteoclasts with 
subsequent bone resorption (Dutzan et al. 2009, Hernandez et al. 2011). 
It has been found that periodontal regeneration by conventional methods, for 
example, scaling, root planning, bone grafts, and barrier membranes might be 
effective in some cases. However, these conventional methods have shown 
some limitations with certain extensive cases. That is the main reason of the 
great concern about periodontal regeneration aided by the use of stem cells 
(Tan et al. 2009, Mudda and Bajaj 2011, Zhao et al. 2008, Park et al. 2011). 
 
1.3 Periodontal regeneration by applying stem cells 
 
Attempts of periodontal regeneration have been focusing mainly on 
regenerating the resorbed lost alveolar bone with the help of bone grafts, and 
alloplastic materials (Mudda and Bajaj 2011). Recently, with the great 
revolution in the field of regeneration using stem cell therapy (regenerative 
medicine), periodontists began to think and dream about achieving complete 
periodontal regeneration using stem cell therapy even in extensive cases in 
which conventional methods are not sufficient (Zhao et al. 2008, Mudda and 
Bajaj 2011, Shi et al. 2005, Chen YL et al. 2008). 
Stem cells are undifferentiated cells that can self-renew, proliferate, and give 
birth to daughter cell lines which are able to differentiate into many mature cell 
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There are three main types of stem cells: totipotent, pluripotent, and 
multipotent stem cells. 
 
a) Totipotent stem cells 
 
Including embryonic stem cells, they are derived from the inner cell 
mass of the blastocyte, and they exhibit the ability to give birth to 
daughter cell lines that are able to differentiate to a large variety of 
tissues, approximately more than 200 different cell types (Umehara et 
al. 2007, Leo and Grande 2006, Ivanovski et al. 2006, Kiuru et al. 
2009). 
 
b) Pluripotent stem cells 
 
They are similar to multipotent stem cells. However, they have the 
potential to form trophoblasts as well (Evans and Kaufman 1981, Jiang 
et al. 2002, Kiuru et al. 2009). 
 
c) Multipotent stem cells 
 
They show the least stemness characteristics of the three types of 
stem cells as their daughter cell lines can only differentiate to a few 
specific tissue types. However, they are preferred over the other stem 
cell types in a potential periodontal regeneration therapy due to the 
ease of obtaining and isolating them. Also, they are preferred regarding 
the ethical aspect (Ivanovski et al. 2006, Fortier 2005, Jiang et al. 
2002). 
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1.3.1 Mesenchymal stem cells (MSCs) 
 
The concept of a mesenchymal stem cell arose from the work of Friedenstein 
and colleagues four decades ago (Friedenstein et al. 1966, 1970, Jones and 
McGonagle 2008). MSCs are like all stem cells; they can self-renew, and they 
have the ability to proliferate and give birth to daughter cell lines which are 
able to differentiate to other mature cell types that have specific shapes, 
characteristics, and functions, and that is what makes MSCs play an 
important role in adult tissue repair (Song et al. 2006, Singer and Caplan 
2011, Pittenger et al. 1999, Phinney and Prockop 2007, Fuchs 2012). 
 
1.3.2 Bone marrow derived mesenchymal stem cells  
 
Bone marrow mesenchymal stem cells, also known as bone marrow stromal 
cells (BMSCs) are isolated easily from single cell suspensions from bone 
marrow aspirates, as they adhere to the plates of the cell culture and show 
the characteristics of clonogenicity, this means that they are able to form a 
colony when they are being cultured with very low density, and that is what 
made the bone marrow to be considered as one of the most important 
sources of MSCs (Tan et al. 2009, Ye et al. 2012, Friedenstein et al. 1992, 
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1.3.3 MSCs for periodontal regeneration 
 
The most important problem that has to be faced during the regeneration of 
the periodontium is the complex nature of the tissues that should be 
regenerated (soft and hard tissues like alveolar bone, cementum, and PDL). 
Due to this complex structure of the periodontium, its complete regeneration 
would require a multipotent cell population to be able to differentiate to these 
different tissues (Ivanovski et al. 2006, Maria et al. 2007). The mesenchymal 
origin of the different periodontal structures made a great concern to be 
directed towards the MSCs as a preferable source of stem cells for the 
regeneration of periodontal defects (Hasegawa et al. 2006, Maria et al. 2007, 
Kawaguchi et al. 2004). 
 
1.3.4 BMSCs versus PDL derived stem cells in 
periodontal regeneration 
 
It is believed that BMSCs are preferred over PDL derived stem cells in 
periodontal regeneration due to their superior availability, their better 
multilineage potential, and better, easier, and more comfortable culture 
properties, especially in the primary culture stage (Tan et al. 2009, Zhao et al. 
2008). Furthermore, the way to expand a great number of PDL stem cells in a 
short period of time is still an unsolved problem (Zhao et al. 2008). On the 
other hand, the heterogeneous nature of the PDL containing blood vessels, 
connecting tissue fibers, and a great variety of cells, for example, fibroblasts, 
macrophages, undifferentiated ectomesenchymal cells, cementoblasts, 
cementoclasts, osteoblasts and osteoclasts, cell of Malassez, and cells of 
vascular and neural nature, made the PDL to be regarded as an unreliable 
source of pure homogeneous populations of stem cells (Tan et al. 2009, Zhao 
et al. 2008).  
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From another aspect, some recent studies suggested that the PDL derived 
cells possess functional characteristics similar to those of leucocytes and 
macrophages that are involved in classical innate immunity (Souza et al. 
2010, Almasri et al. 2007, Jönsson et al. 2008, 2009). These studies showed 
that the PDL cells can express and produce cytokines and chemokines in 
response to inflammatory stimulants, such as bacterial lipopolysaccharides, 
suggesting that PDL derived cells can act as immune cells producing 
inflammatory mediators under periodontopathic bacterial stimulation, and 
increasing the host-immune inflammatory response with subsequent 
increased periodontal destruction (Almasri et al. 2007, Jönsson et al. 2008, 
2009, 2011). Another pervious study that was performed by Yamaji et al. also 
suggested that in vitro stimulation of the PDL derived fibroblasts with the 
lipopolysaccharides of the Porphyromonas gingivalis, stimulates their 
secretion of IL-6, and IL-8 into the culture medium (Yamaji et al. 1995). 
  
1.3.5 Immortalization of the BMSCs  
 
Although bone marrow is a preferable source of MSCs (Bianco et al. 2001), 
the amount of isolated MSCs from a single bone marrow aspirate is of low 
frequency to be used in vivo. Therefore, in vitro culture and expansion of 
isolated MSCs is necessary in order to get a large population that can be 
successfully applied in vivo for complete tissue regeneration (Böcker et al. 
2008). 
Unfortunately, studies showed that human MSCs (hMSCs) undergo 
senescence-associated growth arrest when they are cultured in vitro; as they 
can give rise to a maximum of 24-40 population doublings, and then their 
proliferation ability is over, this phenomenon is termed as replicative 
senescence (Böcker et al. 2008, Stenderup et al. 2003, DiGirolamo et al. 
1999). This replicative senescence was found to be a result of telomere 
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shortening of chromosomes during replication and division of the cells (Böcker 
et al. 2008, Baxter et al. 2004). 
In vivo, telomere shortening has been found to be stopped by the action of the 
telomerase enzyme, which is a ribonuclear protein complex consisting of an 
integral RNA which serves as telomeric template and a catalytic subunit with 
reverse transcriptase activity (Counter et al. 1997, Lendvay et al. 1996, 
Zimmermann et al. 2003). Unfortunately, it has been found that hMSCs lack 
the telomerase activity in vitro, and thus result in the replicative senescence 
(Zimmermann et al. 2003, Simonsen et al. 2002).  
The hTR gene encodes the RNA component of telomerase (Feng et al. 1995), 
whereas the TP1/TLP1 gene encodes a telomerase-associated protein of 
unknown function (Harrington et al. 1997, Nakayama et al. 1997). 
Unfortunately, attempts that were made to express these components in the 
cells did not always result in telomerase activity (Feng et al. 1995, Avilion et 
al. 1996, Harrington et al. 1997, Nakayama et al. 1997). Meyerson et al. 
managed to clone a human cDNA that encodes the putative telomerase 
catalytic protein subunit (Meyerson et al. 1997, Nakamura et al. 1997). This 
protein, which was originally named hEST2 (Meyerson et al. 1997) or hTRT 
(Nakamura et al. 1997) has been renamed TERT, according to the HUGO 
Nomenclature Committee of the Genome Database. 
Based on these previous results, the attempts of in vitro immortalization of 
stem cells arose by the trial of introducing the gene coding for human TERT 
(hTERT) into the MSCs (Burns et al. 2005, Pfeifer et al. 2002). Neoplastic 
transformations were always found in most cases that used the gamma 
retroviruses as vectors for ectopic expression of hTERT into MSCs (Böcker et 
al. 2008, Burns et al. 2005, Pfeifer et al. 2002, Kohn 2007). That is the reason 
that made scientists think about the lentiviruses as vectors for the ectopic 
expression of the hTERT into the MSCs (Böcker et al. 2008). Unlike the 
retroviruses, no malignant transformations were observed in the MSCs after 
the ectopic expression of the hTERT using lentiviruses (Böcker et al. 2008, 
Docheva et al. 2010, Harley 2002), and thus, and a new cell line of 
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immortalized MSCs was introduced, in which the cells are showing no 
malignant transformations, and do not undergo replicative senescence when 
they are cultured in vitro (Böcker et al. 2008). 
Böcker et al. managed to produce an immortalized cell line of hTERT hMSCs, 
they gave it the name “SCP-1” (single cell picked clones) in which a single 
hMSC was picked under the light microscope at the 5th passage after being 
transduced with the hTERT using the lentivirus, and the number 1 was given 
to distinguish this cell line from other 22 single picked clones cell lines (Böcker 
et al. 2008). 
This study mainly concentrates on the immortalized SCP-1 cell line, and its 
ability to withstand culturing and the incubation with the bacteria that are 
involved in periodontitis, in order to support the idea of using the MSCs as a 
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1.4 Bacteria involved in periodontitis 
 
As it has been stated before, periodontitis is a bacterial biofilm induced 
inflammatory disease that results in the destruction of the periodontal 
components including alveolar bone, cementum, gingiva, and PDL (Tan et al. 
2009, Yanagita et al. 2011, Park et al. 2011, Hernandez et al. 2011). 
Periodontal disease is a result of the interaction of different etiologic factors, 
including the formation of bacterial biofilm in the subgingival 
microenvironment, dental health care, and the genetic susceptibility of the 
individual host (Offenbacher 1996, Kinane 2001). The major destruction of the 
periodontal apparatus associated with periodontitis results from the activation 
of the host’s immune-inflammatory response to the bacterial virulence factors, 
mainly endotoxins (Offenbacher 1996, Kinane 2001, Hernandez et al. 2011). 
Although more than 400 different species of bacteria were found and detected 
in the oral cavity, only a limited number of bacteria have been found to act as 
periodontal pathogens (Salari and Kadkhoda 2004).  
Many statistical studies have been carried out on a large variety of patients in 
order to detect and isolate the bacterial strains with the highest incidence in 
the periodontal pockets that are involved in chronic periodontitis (Salari and 
Kadkhoda 2004, Socransky et al. 2002, Colombo et al. 2009). Certain groups 
of Gram-negative bacteria have been found consistently in periodontal 
lesions, among these groups are, Actinobacillus actinomycetemcomitans, 
Porphyromonas gingivalis, Prevotella intermedia, Eikenella corrodens, 
Capnocytophaga species, and Spirochetes (Salari and Kadkhoda 2004, 
Haffajee and Socransky 1994, Mandell 1984, Colombo et al. 2009). For 
example, in the study that was carried out by Salari and Kadkhoda in 2004, 
bacterial samples were collected from the periodontal pockets of 203 patients 
(92 males and 111 females). Samples were cultured under anaerobic and 
capnophilic conditions. Isolated bacteria were found to be Actinobacillus 
actinomycetemcomitans (26.8%), Porphyromonas gingivalis (21.9%), 
Capnocytophaga sputigena (16.7%), Eikenella corrodens (13.2%), Prevotella 
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intermedia (10.5%), Prevotella disiens (3.1%), Peptostreptococcus micros 
(2.9%), Capnocytophaga gingivalis (2.2%), Prevotella corporis (1.8%), 
Peptostreptococcus magnus (1.3%) and Fusobacterium nucleatum (0.4%). 
No periodontopathogenic bacterial growth was observed in 14 of the samples 
(6.2%) (Salari and Kadkhoda 2004). Another study by Mandell in 1984 
reported that Eikenella corrodens and Actinobacillus actinomycetemcomitans 
have been found together in a certain type of periodontitis known as juvenile 
periodontitis (Salari and Kadkhoda 2004, Mandell 1984). Juvenile periodontitis 
(also known as aggressive periodontitis), is a certain clinical form of 
periodontal disease, which mainly occurs in individuals between the age of 12 
and 20 years, and demonstrates a rapid aggressive loss of supporting 
alveolar bone around the first permanent molars and incisors (Salari and 
Kadkhoda 2004, Mandell 1984, Gajardo et al. 2005, Takeuchi et al. 2003). 
And therefore, this study concentrates mainly on these two types of bacteria 
(Actinobacillus actinomycetemcomitans and Eikenella corrodens) which were 
found to be highly involved in both chronic (the common type of periodontitis 
which is found in adults) and aggressive types of periodontitis (Salari and 
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1.4.1 Actinobacillus actinomycetemcomitans  
 
Actinobacillus actinomycetemcomitans is a highly pathogenic microorganism 
that is considered as the most important periodontal pathogen in both chronic 
and aggressive types of periodontitis (Salari and Kadkhoda 2004, Sakurai et 
al. 2007, de Graaff et al. 1989, Riggio et al. 1996). Actinobacillus 
actinomycetemcomitans is a Gram-negative bacterium, which is spherical or 
rod-shaped. It is a facultative anaerobe, which can grow under either aerobic 
or anaerobic conditions. Actinobacillus actinomycetemcomitans is a typical 
cause of periodontitis but it may also be related to systemic infections and 
arterial plaques (Lakio et al. 2003). It was first discovered by Klinger in 1912; 
who isolated this bacterium from cases of actinomycosis (de Graaff et al. 
1989). Since this bacterium was frequently isolated in close association with 
Actinomyces israelii in actinomycotic lesions, Klinger proposed the name 
actinomycetemcomitans. The epithet "Actino" in the generic name 
Actinobacillus refers to the phenomenon that bacterial colonies grown on solid 
media produce an internal star-shaped morphology (de Graaff et al. 1989). 
Serological investigations led to the recognition of five different serotypes of 
Actinobacillus actinomycetemcomitans (from a to e) (Kaplan et al. 2001, 
Ebersole and Cappelli 1994, Perry et al. 1996). However, some studies have 
proposed the presence of another serotype (6th serotype) of the Actinobacillus 
actinomycetemcomitans (serotype f) (Kaplan et al. 2001). As many other 
types of Gram-negative bacteria Actinobacillus actino-mycetemcomitans 
contains a lipopolysaccharide membrane. This lipopolysaccharide membrane 
contains a high molecular mass O-polysaccharide (O-PS) component. In this 
O-PS component, the immunodominant outer membrane antigen of the 
Actinobacillus actinomycetemcomitans is located, and that is what made a lot 
of scientists consider the lipopolysaccharide of the Actinobacillus 
actinomycetemcomitans as a very important virulence factor of this strain of 
bacteria (Lakio et al. 2003, Kaplan et al. 2001, Ebersole and Cappelli 1994).  
 




Figure 3: Image of Actinobacillus actinomycetemcomitans colony grown on 
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1.4.2 Eikenella corrodens  
 
Eikenella corrodens is a Gram-negative facultative anaerobic bacterium that is 
found in the oral cavity, upper respiratory, and intestinal and genital tracts 
(Fujise et al. 2004, Chen CK et al. 1989, 1990, Chen CK and Wilson 1992). 
Eikenella corrodens is mainly considered as a periodontopathogen; as many 
statistical studies have revealed the large increase of its numbers in the 
periodontal pockets of the patients suffering from periodontitis (Salari and 
Kadkhoda 2004, Mandell 1984, Socransky et al. 2002, Colombo et al. 2009, 
Fujise et al. 2004). Eikenella corrodens can also act as a causative agent for 
some serious extraoral infections either alone as the only infective agent or in 
combination with other bacteria (Chen CK et al. 1990, Suwanagool et al. 
1983). Some studies have considered Eikenella corrodens as a commensal 
bacterium in the oral cavity (Chen CK et al. 1990), as alone, it cannot produce 
periodontitis, unlike the Actinobacillus actinomycetemcomitans in the 
predominantly monoclonal periodontal infection with Actinobacillus 
actinomycetemcomitans. However, it is   confirmed that Eikenella corrodens 
plays a strong synergistic role in multiclonal periodontal infections, especially 
together with Actinobacillus actinomycetemcomitans (Fujise et al. 2004, Chen 
CK et al. 1989, Mandell et al. 1987). Eikenella corrodens can colonize the 
subgingival sites much more efficiently than Actinobacillus 
actinomycetemcomitans, and thus decrease the defense ability of the gingival 
crevice against Actinobacillus actinomycetemcomitans (Fujise et al. 2004, 
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1.5 Aim of the study 
 
This study mainly concentrates on the immortalized hTERT hMSCs, and their 
ability to withstand culturing and incubation with the bacteria that are involved 
in periodontitis, namely, Actinobacillus actinomycetemcomitans, and Eikenella 
corrodens, in order to elucidate the effects of bacteria on the immortalized 
MSCs. 
Individual aims: 
1. Observing the ability of the MSCs to withstand and survive culturing 
and incubation in the normal cell culture medium together with the 
viable periodontopathic bacteria after pushing them in a bacteriostatic 
state. 
 
2. Investigating the capability of osteogenic differentiation of the MSCs 
after being cultured with periodontal pathogens. 
 
3. Determining the future possibility of using MSCs as a successful 
means of stem cell based complete regeneration of damaged 
periodontium in periodontal diseases. 
 
   2 Materials and methods 
 17 




Bacteria were obtained with the help of the Microbiology Department, Georg-
August-University, Göttingen.  
Two main strains of bacteria were obtained:  
 Actinobacillus actinomycetemcomitans (ATCC number 29522) 
 Eikenella corrodens (ATCC number 23834). 
 
As it has been stated before, both of them are facultative anaerobic strains of 
bacteria that are involved in periodontitis. Both strains of bacteria were 
intended for the first time to be grown  in the same culture medium that is 
used for the normal cell culture; DMEM (Dulbecco’s modified eagle’s medium) 
(Gibco life technologies, USA) and 10 %FBS (fetal bovine serum) (Invitrogen, 
USA) as a nutrient. After one week of incubation of bacteria in the normal cell 
culture medium growth of bacteria was then tested by streaking bacterial cell 
culture medium on blood agar plates. Streaking is a technique used with 
bacterial culturing on agar plates, in this technique a drop of the bacterial 
culture medium is carried on the end of a thin sterile loop of wire, which is 
known as an inoculator. The bacterial culture medium is then streaked across 
the surface of the blood agar leaving bacteria behind. A higher number of 
bacteria will be left behind at the beginning of the streak and a lower number 
will be left at the end. At a certain point during a successful streak, the 
number of bacteria deposited on the agar will be such that distinct individual 
colonies will grow which may be removed later for further culturing, using 
another sterile loop. After streaking of the bacteria on the blood agar plates, 
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bacterial colonies were found to be growing after 24 hours in both 
Actinobacillus actinomycetemcomitans and Eikenella corrodens strains, 
indicating the ability of both of the bacterial strains to survive and grow in the 
cell culturing medium.  
Bacterial growth was then intended to be stopped to put both strains of 
bacteria in a bacteriostatic state. This was managed by: 
 Only 1% gentamycin in case of Eikenella corrodens. 
 1% gentamycin and 24 hours incubation of the bacteria in -20°C in 
case of Actinobacillus actinomycetemcomitans. 
After pushing the bacteria in the bacteriostatic state, bacterial growth on blood 
agar plates was then checked again to confirm the bacteriostatic state and no 
bacterial colonies were found to be growing out of the streaks indicating the 
stop of the bacterial growth. Bacteria in the DMEM were counted according to 
the McFarland standards and the exact counts of the bacterial colonies were 
obtained. 
 Eikenella corrodens 9 x 105 bacterial colony/µl. 
 Actinobacillus actinomycetemcomitans 22 x 105 bacterial colony/µl. 
Bacteria were then diluted with normal DMEM to a concentration of              
40 bacterial colony/µl, and were kept in -20 °C to maintain their bacteriostatic 
state. Undiluted bacteria were kept in -80 °C. 
McFarland turbidity standards are used to standardize the approximate 
number of bacteria in a liquid suspension (water, saline or liquid growth 
medium) by visual or spectrophotometric comparing the turbidity of a test 
suspension with the turbidity of a McFarland standard. The corresponding 
bacterial count in a comparable suspension is listed below each of the 
McFarland standards. McFarland standards are prepared by adding barium 
chloride to sulfuric acid to obtain a barium sulfate precipitate. By adjusting the 
volumes of these two reagents, standards of varying degrees of turbidity can 
be prepared to represent several different concentrations of bacteria. The 
standard most commonly used in the clinical microbiology laboratory for 
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routine antimicrobial susceptibility tests is 0.5 which represents 1.5 X 108 
bacteria/ml. McFarland standards are commercially available from several 
sources. 
 
2.2 Cell culture 
 
The cell line that has been used in this study is called SCP-1 cell line. Böcker 
et al. managed to produce an immortalized cell line of hTERT hMSCs, they 
gave it the name SCP-1, single cell picked clones, in which a single hMSC 
(purchased from Cambrex Corporation, East Rutherford, NJ, USA) was 
picked under the light microscope at the 5th passage after being transduced 
with hTERT using lentivirus, and the number 1 was given to distinguish this 
cell line from other 22 single picked clones cell lines SCP.  
The SCP-1 cell line was transferred to Prof. Dr. med. Nicolai Miosge, Georg-
August-University as a gift from Prof. Dr. med. Matthias Schieker, Faculty of 
Medicine, München University, who participated in the production of the SCP-
1 cell line.  
In this study, the MSCs were first incubated alone in the normal cell culture 
medium (DMEM, 10% FCS, and 1% gentamycin). Bacteriostatic 
Actinobacillus actinomycetemcomitans and Eikenella corrodens were then 
added to be incubated with the MSCs within the same flasks with the ratios of: 
 1 bacterial colony:1 cell. 
 1 bacterial colony:100 cells. 
 2 bacterial colony:1 cell. 
 Controls without bacteria, just with the normal cell culture medium 
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According to this, 7 different combinations were obtained: 
1. AA1: MSCs with Actinobacillus actinomycetemcomitans with the ratio 
of 1:1. 
2. AA100: MSCs with Actinobacillus actinomycetemcomitans with the 
ratio of 1:100. 
3. AA2: MSCs with Actinobacillus actinomycetemcomitans with the ratio 
of 2:1. 
4. EC1: MSCs with Eikenella corrodens with the ratio of 1:1. 
5. EC100: MSCs with Eikenella corrodens with the ratio of 1:100. 
6. EC2: MSCs with Eikenella corrodens with the ratio of 2:1. 
7. Control: without bacteria, just normal cell culture medium. 
 
The cells could not manage to survive the high ratio of 2:1, and thus AA2 
and EC2 were lost, and eventually 5 different experiments were carried on:  
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2.3 Determination of the growth and proliferation 
rates of the MSCs with different ratios of bacteria 
 
Immortalized MSCs were then cultured with both of the bacterial strains for 2 
months starting from passage 77. Cells were trypsinized, harvested, and 
counted (by the Cellometer) during the 2 months period of incubation. 
Passaging of the cells was carried out every 6 days, and the cell culture 
medium was changed with the bacteria every 3 days. Cell culturing started 
with the number of 8x105 cells per each flask (with a growth area of 75 cm2) at 
the beginning of each passage. After the incubation of the two strains of the 
bacteria with the immortalized MSCs for 2 months, growth curves were then 
blotted based on the cell counts that were obtained from the counting of the 
cells. 
 
2.3.1 The Cellometer Auto T4 (Nexcelom Bioscience)  
 
The Cellometer Auto T4 utilizes bright field imaging and pattern-recognition 
software to quickly and accurately identify and count individual cells. Cell 
count, concentration, diameter, and percentage of viability are automatically 
calculated and reported within 30 seconds. In comparison with the manual 
counting, the Cellometer Auto T4 is 10 times faster and more precise; as with 
a manual haemocytometer it would take at least 5 minutes to count 1 x 106 
cells. Moreover, counting of live and dead cells is a much more complicated 
process, and sometimes it may take twice as long. The Cellometer Auto T4 
cell counter is able to calculate the cell count, the concentration of live and 
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Preparing the cells to be counted by the Cellometer:  
 Discard the cell culture medium with the bacteria by pouring them out 
of the flasks. 
 Wash the flasks with 1xPBS (phosphate buffer saline) to ensure the 
total removal of the DMEM from the flasks, and to allow proper action 
of trypsin.  
 Add 2.5ml 1x trypsin per flask, and leave it for 4 minutes to detach the 
cells from the bottom of the flasks. 
 Tap on the sidewalls of the flasks to ensure the total detachment of the 
cells from the bottom of the flasks. 
 Add 2.5ml DMEM to a 15ml Falcon tube. 
 Add the trypsin with the cells to the 2.5ml DMEM in the 15ml Falcon 
tube to stop the action of the trypsin. 
 Transfer the 15ml Falcon tube to the centrifuge (Eppendorf centrifuge 
5810) and centrifuge with 1200 rpm for 10 minutes, and then discard 
the supernatant solution to obtain the cell pellet. 
 Resuspend the cell pellet in 1ml 1xPBS. 
 Pipet 20µl of the cell-PBS solution on the counting plate. 
 Use the Cellometer for counting the cells. The Cellometer indicates the 
count of the cells/ml, and that is why the cell pellet should be dissolved 
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2.3.2 Fluorescence-activated cell sorting (FACS) 
analysis for ki-67 
 
The proliferation and the growth rates of the cells were also checked by the 
FACS analysis for the ki-67 protein.  
Intracellular staining of the cells with ki-67 for the FACS analysis: 
 Discard the cell culture medium with the bacteria by pouring them out 
of the flasks. 
 Wash the flasks with 1xPBS to ensure the total removal of the DMEM 
from the flasks, and to allow proper action of the trypsin.  
 Add 2.5ml 1x trypsin per flask, and leave it for 4 minutes to detach the 
cells from the bottom of the flasks. 
 Tap on the sidewalls of the flasks to ensure the total detachment of the 
cells from the bottom of the flasks. 
 Add 2.5ml DMEM to a 15ml Falcon tube. 
 Add the trypsin with the cells to the 2.5ml DMEM in the 15ml Falcon 
tube to stop the action of the trypsin. 
 Transfer the 15ml Falcon tube to the centrifuge (Eppendorf centrifuge 
5810) and centrifuge with 1200 rpm for 10 minutes, and then discard 
the supernatant solution to obtain the cell pellet. 
 Resuspend the cell pellet in 1ml 1xPBS. 
 Centrifuge with 1200 rpm for 10 minutes, and then discard the 
supernatant solution to obtain the cell pellet. 
 Resuspend the cell pellet in 100µl FIX&PERM Medium A (Invitrogen, 
USA), and leave it for 20 minutes in room temperature for the fixation 
of the cells. 
 After 20 minutes of incubation in room temperature, dilute with 3ml 
1xPBS and then centrifuge again with 1200 rpm for 10 minutes. 
 Discard the supernatant solution to obtain the cell pellet again. 
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 Resuspend the cell pellet in 100µl FIX&PERM Medium B (Invitrogen, 
USA) for the permeabilization of the cells.  
 Add 2µl of the ki-67 antibody (1:50 dilution) (Dako) to the previous 
solution and leave the whole mixture for 20 minutes in room 
temperature (not added to the iso and the negative controls). 
 After 20 minutes of incubation in room temperature, dilute with 3ml 
1xPBS, and then centrifuge with 1200 rpm for 10 minutes. 
 Discard the supernatant solution to obtain the cell pellet again. 
 Resuspend the cell pellet in 100µl 1xPBS. 
 Add 1µl of the secondary antibody (anti-mouse IgG FITC) (KPL, USA) 
to the previous solution, and leave the whole mixture for 20 minutes in 
room temperature (not added to the negative control). 
 After 20 minutes of incubation in room temperature, dilute with 3ml 
1xPBS, and then centrifuge with 1200 rpm for 10 minutes. 
 Discard the supernatant solution to obtain the cell pellet again. 
 Resuspend the cell pellet in 1xPBS.  
 The sample is then analyzed by the FACS analysis apparatus 








   2 Materials and methods 
 25 
2.4 Testing the MSCs for stem cell markers after 
incubation with bacteria 
 
2.4.1 Testing the MSCs for the stem cell markers 
(CD44, CD29, CD166, and CD105) with the help of 
immunohistochemistry after 3 weeks of incubation 
with bacteria 
 
After 3 weeks of incubation of the cells with the bacteria, cells were tested for 
the stem cell markers CD44, CD29, CD166, and CD105 to confirm their 
stemness after the period of the incubation. This was done according to the 
following protocol: 
 Cells (1000 cells/well) are cultured and incubated with the bacteria in 
24 well plates till they are 80% confluent.  
 Discard the cell culture medium using a small suction tip. 
 Wash one time with 1xPBS 1ml/well. 
 Remove the 1xPBS using a small suction tip.  
 Add 70% Ethanol (1ml/well) from 4°C for 10 minutes for fixation of the 
cells.  
 Wash with 1xPBS for 2 or 3 times. 
 Add the primary antibody with the concentration of 1:50 diluted in 
1xPBS (for each well 300 µl of the diluted antibody are required), 
thereafter, the cells are incubated with the antibody for 60 minutes in 
37°C (add 1xPBS only for the iso and negative controls). 
 Discard the antibody using a small suction tip. 
 Wash twice with 1xPBS.  
 Add the secondary antibody anti-mouse IgG FITC (KPL, USA) with the 
concentration of 1:100 diluted in 1xPBS, for each well 300 µl of diluted 
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antibody are required, then the cells are incubated with the 2ry antibody 
for 30 minutes in 37°C. This step is done only for the uncoupled 
antibodies (CD166), and the isocontrol, while for the coupled 
antibodies (CD44, CD 105, and CD29), and the negative control only 
1xPBS is added. 
 Wash twice with 1xPBS.  
 For counterstaining the DAPI is added with the concentration of 1:1000 
diluted in H2O for 10 minutes (300µl/well) in room temperature. 
 Wash twice with 1xPBS. 
 Seal with a glass cover. 
 
2.4.2 Testing the MSCs for the stemness markers 
(Klf4 and C-myc) genes and their associated effects 
on the osteogenic genes (Runx2 and Col1) using the 
real time PCR after 2 months of incubation with 
bacteria 
 
2.4.2.1 Isolation of the RNA from the MSCs 
 
An RNeasy isolation kit (QIAGEN, Hamburg) has been applied for these 
procedures.   
 Discard the cell culture medium with the bacteria by pouring them out 
of the flasks. 
 Wash the flasks with 1xPBS to ensure the total removal of the DMEM 
from the flasks, and allow proper action of the trypsin.  
 Add 2.5ml 1x trypsin per flask, and leave it for 4 minutes to detach the 
cells from the bottom of the flasks. 
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 Tap on the sidewalls of the flasks to ensure the total detachment of the 
cells from the bottom of the flasks. 
 Add 2.5ml DMEM in 15ml Falcon tube. 
 Add the trypsin with the cells on the 2.5ml DMEM to the 15ml Falcon 
tube to stop the action of the trypsin. 
 Transfer the 15ml Falcon tube to the centrifuge (Eppendorf centrifuge 
5810) and centrifuge with 1200 rpm for 10 minutes, and then discard 
the supernatant solution to obtain the cell pellet. 
 Resuspend the cell pellet in 1ml 1xPBS, and put the solution in a 1.5ml. 
 Transfer the Eppendorf cups to the centrifuge (Eppendorf centrifuge 
5415R, Germany), and centrifuge with 2.3 rpm for 10 minutes, and 
then discard the supernatant solution to obtain the cell pellet in the 1.5 
Eppendorf cups.  
 Prepare the RLT buffer (QIAGEN, Hamburg) by adding: 
A. 350µl of RLT lysis buffer (QIAGEN, Hamburg) with  
B. 3.5µl of β-Mercaptoethanol (2-Mercaptoethanol)  
This amount is used for a cell pellet containing from 500 till 
1,000,000 cells, and if the cells are more than 1,000,000 cells, then 
the amount of the RLT buffer should be doubled. 
 Add the 350µl RLT buffer onto the cell pellet, and then vortex properly 
to allow the solution to be in contact with all of the cells, and leave it for 
2 minutes to give time for the lysing action of the RLT buffer. 
 Apply the whole solution of the cells and the RLT buffer in a shredder 
vial (QIAGEN, Hamburg), the shredder separates the damaged cell 
skeleton from the contents of the cells. 
 Transfer the shredder vial with the solution to the centrifuge (Eppendorf 
centrifuge 5415R), then centrifuge with full speed for 2 minutes, then 
discard the filter (purple part) of the shredder as the cell contents with 
the solution would have been passed through the filter to the tube part 
of the shredder. 
 Add 350µl of 70% ethanol to the previous solution in the tube part of 
the shredder. 
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 Take the whole solution from the tube of the shredder, and pipet it onto 
an RNA easy column, and then centrifuge with the Eppendorf 
centrifuge 5415R, with 10.000 rpm for 15-30 seconds to separate the 
RNA from the rest of the contents of the cells. 
 Discard the supernatant solution in the tube of the RNA easy column, 
as the RNA component will be trapped by the filter of the RNA easy 
column (the pink part). 
 Wash the RNA with 700µl of the RW1 wash buffer (QIAGEN, Hamburg) 
by pipetting the buffer in the RNA easy tube. It is important in this step 
not to touch the filter of the RNA easy tube with the pipet as it traps the 
RNA.  
 Centrifuge with 10,000 rpm for 15-30 seconds, and then discard the 
solution in the tube part of the RNA easy column. 
 Wash another time with 500µl of the RPE buffer (QIAGEN, Hamburg) 
and centrifuge with 10,000 rpm and then get rid of the solution (this 
step is repeated twice). 
 Centrifuge with the full speed for 1-2 minutes to nearly dry the RNA 
from the solution.  
 Take the filter (pink part) of the RNA easy column with the isolated 
RNA trapped in it, and put it on the top of an RNA free safe lock tube 
(QIAGEN, Hamburg). 
 Add 30µl of DEPC water in the filter (pink part) of the RNA easy 
column. 
 Leave the water for 5 minutes at room temperature. 
 Centrifuge for 1 minute with 10,000 rpm, the centrifugation will allow 
the RNA with the DEPC water to pass through the filter into the RNA 
free tube. 
 Use the NanoDrop apparatus (PeqLab) to determine the amount of the 
nucleic acid that is isolated from the cells. 
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2.4.2.2 Transcription of the RNA to cDNA 
 
In this procedure a reverse transcription kit (QIAGEN, Hamburg) is required. 
Quantiscript reverse transcription procedures: 
 Prepare the master mixture (always 14µl) in a 1.5ml Eppendorf cup.  
 The master mixture is composed of:  
 2µl gDNA-wipeout Buffer (QIAGEN, Hamburg). 
 1µl of the isolated RNA mixture (up to 1µg/µl and minimum 
200ng/µl).  
 11µl RNase free water (QIAGEN, Hamburg).   
Both the RNA and the RNase free water are variable according to the 
amount of the RNA which is isolated, so if the amount is less than 
200ng/µl, the RNA mixture should be increased and the RNase free 
water should be decreased in an inverse relationship, so that both of 
them would not exceed 12µl and thus the master mixture would not 
exceed 14µl. 
 Heat the master mixture (14µl) at 42 °C for 2 minutes in the 
Thermomixer (Eppendorf thermomixer comfort, Germany)    
 Remove the master mixture (14µl) from the Thermomixer and then add 
to it: 
 4µl RT-Buffer (QIAGEN, Hamburg). 
 1µl reverse transcriptase enzyme (QIAGEN, Hamburg). 
 1µl RT-primers (QIAGEN, Hamburg).  
And thus, eventually a mixture of 20µl is obtained.  
 Transfer the 20µl mixture to the Thermomixer at 42°C for 15 minutes to 
start the reaction of the reverse transcriptase enzyme. 
 Finally, put the 20µl mixture in the Thermomixer at 95°C for 3 minutes 
to stop the reverse transcriptase action.  
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For the cDNA to be used for the PCR it should be diluted in DEPC water to 
the concentration of 1 cDNA ng/µl. 
 
2.4.2.3 Preparing the sample for the PCR machine 
 
The Klf4, and the C-myc primers were designed with the help of primer3 
program, (http://frodo.wi.mit.edu/primer3/), and they were manufactured by 
Eurofins MWG Operon company and then their sequences were checked in 
the SeqLab Laboratories. Real time PCR was performed using the Eppendorf 
realplex2 Mastercycler epgradient S PCR machine. β2M was used as a 
housekeeping gene. 
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Preparing the sample for real time PCR: 
 First the master mixture is prepared. The master mixture is composed 
of (for each well in the PCR plate) : 
 2µl of the primer.  
 4.5µl SYBR green (Invitrogen, USA) which is the fluorescence 
marker of the amplified cDNA.  
 2.5µl DEPC water (RNase free water). 
 The 9µl of the master mixture are first added in each well in the PCR 
plate then the 1µl of the cDNA sample that is meant to be amplified is 
added to the master mixture in each well. 
 Finally a mixture of 10µl is obtained per each well in the PCR plate. 
 
The PCR system that was performed works in triplets (three times) for three 
successive days; in order to insure the accuracy of the resulting cycle 
threshold (Ct) values, and to be sure that the results are totally free of any 
technical or handling errors. The resulting 9 Ct values were then analyzed 
with the Pfaffl model, which is a mathematical model for relative quantification 
of the target gene in comparison to a reference (housekeeping) gene (Pfaffl 
2001). 
The Ct value is defined as the number of cycles required for the fluorescent 
signal (by the SYBR green coupling to the amplified cDNA) to cross the 
background threshold (exceeds background level). The Ct values are 
inversely proportional to the amount of target cDNA in the sample (the lower 
the Ct value the greater the amount of target cDNA in the sample). 
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2.5 Osteogenic differentiation of the MSCs after the 
two months of incubation with bacteria 
 
After 2 months of incubation of the cells with bacteria, the cells were then 
transferred to the osteogenic differentiation medium. Cells were divided into 2 
main groups: 
1. Cells which were osteodifferentiated with mesenchymal stem cell 
osteogenic differentiation medium (Promocell GmbH, Heidelberg, 
Germany). The cells in this group were given the names (O-AA1-, 
O-AA100-, O-EC1-, O-EC100-, and O-control). 
2. Cells which were osteodifferentiated with mesenchymal stem cell 
osteogenic differentiation medium and with the addition of the 
bacteria to the osteogenic differentiation medium with the same 
previous ratios of incubation (1:1 and 1:100). The cells in this group 
were given the names (O-AA1+, O-AA100+, O-EC1+, and O-
EC100+). 
 
 (O-AA1+) with 1 bacterial colony (AA):1 cell. 
 (O-AA100+) with 1 bacterial colony (AA):100 cells. 
 (O-EC1+) with 1 bacterial colony (EC):1 cell. 
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3. Thus finally 9 different cell experiments were obtained:  
 1. O-AA1+ 
2. O-AA100+           osteogenic differentiation medium                                  
3. O-EC1+                       with bacteria (+). 
4. O-EC100+ 
 
 5. O-AA1- 
6. O-AA100- 
7. O-EC1-                 osteogenic differentiation medium                        
8. O-EC100-                     without bacteria (-).                                             
9. O-control 
 
2.6 Testing the MSCs for the osteogenic 
differentiation after the incubation with the 
osteogenic differentiation medium 
 
2.6.1 Alkaline phosphatase staining 
 
After 8 days of cell incubation with the osteogenic differentiation medium, cells 
were checked for alkaline phosphatase enzyme activity. An alkaline 
phosphatase staining kit (Sigma-Aldrich, Steinheim, Germany) was applied for 
the alkaline phosphatase staining procedures. 
 
a) Preparing the alkaline staining mixture: 
 
Add 0.1ml sodium nitrate solution on 0.1ml FBB-alkaline solution in a 15ml 
Falcon tube, and then both solutions should be mixed properly and left for 2 
minutes to allow the reaction between them to start. After 2 minutes, add 
4.5ml H2O (room temperature), and 0.1ml naphthol AS-BI alkaline solution 
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onto the previous solutions in the Falcon tube and then the whole mixture 
should be mixed properly. 
 
b) Preparing the fixation solution: 
 
Add 2.5ml citrate solution to 6.5ml acetone and 0.8ml 37% formaldehyde 
solution, and then the whole mixture should be mixed properly. The mixture is 
put in the refrigerator (4°C) to be stable for approximately 4 weeks later.   
 
c) The Permeability solution: 
 
0.125 gram Triton x-100 diluted in 50ml 1xPBS. 
 
d) The procedures:                                 
                                                                                                                                                
 Cells are washed with 1xPBS twice for 15 minutes each. 
 Cells are fixed with the fixation solution for 30 seconds.  
 Wash the cells for 45 seconds with 1xPBS. 
 Add the permeability solution (the triton) for 3 minutes in room 
temperature. 
 Wash the cells many times with H2O until the triton is completely 
removed.  
 Stain the cells with the alkaline staining solution by putting it for 15-
30 minutes at 37°C in a light protected place. 
 Wash the cells for 2 minutes with H2O. 
 Use the neutral red solution for counter staining for 2 minutes in 
room temperature. 
 Wash with tap water. 
 Leave the cells to dry in the air.  
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 Cover the slide with glass cover. 
 
2.6.2 Testing the MSCs for the osteogenic 
differentiation with the immunocytochemistry 
 
After 12 days of incubation with the osteogenic differentiation medium, the 
cells were checked for the osteopontin (an extracellular structural protein, and 
thus an imporant component of the bone, also it acts as an indicator of the 
bone turnover) using immunocytochemistry. 
 Cells (1000 cells/well) are cultured and incubated with the osteogenic 
differentiation medium in 24 well plates till they are 80% confluent.  
 Discard the osteogenic differentiation medium using a small suction tip. 
 Wash one time with 1xPBS 1ml/well. 
 Remove the 1xPBS using small suction tip.  
 Add 70% Ethanol (1ml/well) from 4°C for 10 minutes for fixation of the 
cells.  
 Wash with 1xPBS for 2 or 3 times. 
 Add the osteopontin antibody with the concentration of 1:50 diluted in 
1xPBS (for each well 300 µl of diluted antibody are required), then the 
cells are incubated with the osteopontin antibody for 60 minutes in 
37°C (use 1xPBS only for the iso and negative controls). 
 Discard the antibody using a small suction tip. 
 Wash twice with 1xPBS.  
 Add the secondary antibody, anti-mouse IgG FITC (KPL, USA), with 
the concentration of 1:100, diluted in 1xPBS (for each well 300 µl of 
diluted antibody are required), then the cells are incubated with the 2ry 
antibody for 30 minutes in 37°C (for the negative control no secondary 
antibody is added, only 1xPBS is added). 
 Wash twice with 1xPBS.  
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  For counterstaining DAPI is added with a concentration of 1:1000 
diluted in H2O for 10 minutes (300µl/well). 
  Wash twice with 1xPBS. 
  Seal with a glass cover. 
 
2.6.3 Testing the MSCs for the degree of osteogenic 
differentiation using the real time PCR (testing the 
expression of the Runx2 and Col1 after osteogenic 
differentiation) 
 
After 2 weeks of incubation of the MSCs with the osteogenic differentiation 
medium, cells were tested for the degree of osteogenic differentiation with the 
help of the real time PCR to test for Runx2 and Col1 expression. β2M was 
applied as a housekeeping gene. 
RNA was isolated from the cells and then transcripted into cDNA as stated 
before, then real time PCR was performed with the help of Eppendorf 
realplex2 Mastercycler epgradient S PCR machine. 




3.1 Bacterial growth in the normal cell culture 
medium 
 
After one week of incubation of the bacteria in the normal cell culture medium, 
growth of the bacteria was then observed by streaking the bacterial cell 
culture medium on blood agar plates. In both of the cases, Actinobacillus 
actinomycetemcomitans and Eikenella corrodens, bacterial colonies appeared 
to be growing out of the streaks. This was the first evidence of successful 
growth of periodontal pathogens in the normal cell culturing medium      
(Figure 4). 
After the addition of 1% gentamycin in order to stop bacterial growth to reach 
a bacteriostatic state, growth was then checked again by streaking the 
bacterial cell culture medium again on the blood agar plates. Here, each strain 
of the two strains of bacteria had a different response to the 1% gentamycin. 
 In the case of Eikenella corrodens, no bacterial colonies were found to 
be growing out of the streaks indicating the total stop of the bacterial 
growth, and that the bacteria were now in the bacteriostatic state 
(Figure 5). 
 In the case of Actinobacillus actinomycetemcomitans, there were still 
some bacterial colonies growing out of the streaks indicating that the 
bacteria were still viable. In order to stop the bacterial growth 
completely; bacteria were incubated for 24 hours in -20°C, and then 
checked again for their growth. After one day of incubation in -20 °C, 
the bacterial cell culture medium was streaked again on the blood agar 
plates, but no bacterial colonies were found to be growing out of the 
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streaks indicating a complete stop of the growth of the bacteria, and 
that the bacteria are in the bacteriostatic state. 
 
After the complete stop of the bacterial growth, bacterial colonies were then 
counted with the McFarland standards, and an exact count was obtained for 
each strain. 
 For the Eikenella corrodens 9 x 105 bacterial colony/µl.  
 For the Actinobacillus actinomycetemcomitans 22 x 105 bacterial 
colony/µl. 
 
bacterial colonies                                           
           
Figure 4                                           Figure 5 
 
Figure 4: Blood agar plate showing Eikenella corrodens bacterial growth after 
one week of incubation within the cell culture medium.                                                                                                        
Figure 5: Blood agar plate showing no Eikenella corrodens growth after the 





   3 Results 
 39 
3.1.1 The growth rate of the MSCs during the period 
of two months of the incubation with the bacteria 
 
As it is has been stated before in the materials and methods section, cells 
were incubated with the Actinobacillus actinomycetemcomitans and Eikenella 
corrodens bacteria (Figure 6) with three different ratios (1:1, 2:1, and 1:100) 
for each type of bacteria, and a control without bacterial incubation, thus 
finally 7 different cell combinations were obtained (AA1, AA2, AA100, EC1, 




Figure 6: Bacteria incubated with the cells.  
 
In the cases of AA2 and EC2 the cells could not withstand the high bacterial 
ratio and all of the cells died within:  
 5 days in the case of AA2. 
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Thus, eventually only 5 different experiments were carried on: 
1. AA1                                                  
2. AA100                                               




3.1.2 Counting of the cells with the Cellometer during 
the incubation with the bacteria 
 
During a period of 2 months, cells were passaged and counted regularly with 
the Cellometer every 6 days. The results that were obtained from the 
Cellometer were a little bit fluctuating, this may be due to the fact of the 
fluctuating nature of the proliferation of the stem cells as it is stated by Watt 
and Hogen in 2000 in the Science journal that “although a stem cell has high 
self-renewal capacity, it may actually divide relatively infrequently” (Watt and 
Hogen 2000). However, in general, it can be observed that in most of the 
counts of the cells incubated with the Eikenella corrodens (about 70% of the 
cell counts, in the cases after 6, 18, 30, 36, 42, 54, and 60 days), and in all of 
the counts of the cells (100%) incubated with the Actinobacillus 
actinomycetemcomitans it was interestingly found that the cells that were 
incubated with the higher numbers (ratios) of bacteria, showed higher 
proliferation and growth rates than those incubated with the lower numbers 
(ratios) of bacteria. Moreover, it can be generally stated that the MSCs in 
most of the counts of the cells (about 70% of the cell counts in the cases after 
6, 12, 18, 24, 36, 42, and 54 days) incubated with the higher numbers (ratios) 
(1:1) of Eikenella corrodens exhibited higher proliferation and growth rates 
than those incubated without bacteria (controls). More interestingly, almost all 
of the MSCs in the counts of the cells (about 90% of the cell counts in the 
cases after 6, 18, 24, 30, 36, 42, 48, 54 and 60 days) incubated with the 
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higher numbers (ratios) (1:1) of Actinobacillus actinomycetemcomitans 
exhibited higher proliferation and growth rates than those incubated without 
bacteria (controls) (Table 1, Figure 7). 
As this contradicts common sense at first glance, further extensive 
experiments were carried out to enforce the previous results: 
 Regarding the time interval of the passaging and the cell counting, cells 
were passaged and counted with another time interval (every 4 days) 
over a period of 50 days, and the same relations were obtained 
between the different ratios for both types of bacteria.  
 Regarding the cell number at the beginning of each passage, 2 parallel 
experiments were carried out: 
1. Starting with the number of 8x105 cells per each flask (with 
growth area of 75cm2). 
2. Starting with the number of 2.5x105 cells per each flask (with 
growth area of 25cm2), and for both cases, relations between 
cell counts were consistent with the previously obtained results. 
 Regarding the methodology of cell counting, the counts that were 
obtained from the Cellometer, were confirmed randomly by recounting 
them with the manual haemocytometer. 
 Regarding the possibility of cross contamination of the controls during 
passaging, all flasks were discarded and a new set of flasks were used 











cell line 6 days 12 days 18 days 24 days 30 days 36 days 42 days 48 days 54 days 60 days
EC1 1040000 1100000 1020000 794000 544000 2720000 2280000 1113000 2900000 1810000
EC100 652000 1130000 823000 961000 514000 2260000 1780000 1120000 1500000 1660000
AA1 865000 879000 893000 776000 1240000 2060000 2330000 1390000 2900000 3370000
AA100 840000 691000 722000 731000 694000 1500000 1340000 1114000 1500000 1050000
Control 589000 959000 814000 629000 894000 1330000 2210000 1300000 1380000 1810000  
 
Table 1: Showing the cell counts (with the Cellometer) of the different cell 
experiments (AA1, AA100, EC1, EC100, and control) obtained during a period 










Figure 7: Cell counts (obtained from the Cellometer) of the different cell 
experiments (AA1, AA100, EC1, EC100, and control) obtained during a period 
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3.1.3 FACS (fluorescence-activated cell sorting) 
analysis for ki-67 
 
Results that were obtained from the FACS analysis of the cells for ki-67 
(which is a nuclear protein that is associated with and may be necessary for 
cellular proliferation) enforced the results that were obtained by the cell 
counting with the Cellometer. It was found that the MSCs that were incubated 
with the higher numbers (ratios) of the bacteria (1:1), showed a higher 
percentage of positive cells for the ki-67 than those incubated with the lower 
numbers (ratios) of the bacteria (1:100). Moreover, tendency was seen that 
the cell experiments incubated with the higher numbers (ratios) of bacteria 
(1:1) also exhibited a higher percentage of positive cells for the ki-67 than 
those incubated without bacteria (controls). These results were found to be 
consistent with the both strains of bacteria (Tables 2, 3, and 4, Figures 8, 9a, 
9b, 9c, 10a, 10b, 11a, and 11b).  
FACS analysis of the MSCs for the ki-67 has been repeated three successive 
times to insure the previously obtained results. There was a gap period of one 
week between each FACS analysis to allow the cells to proliferate and reach 
a reasonable number that would be sufficient for each FACS analysis. This 
means that, it is not expected that the percentage of the positive cells for the 
ki-67 will increase with the increase of the period of incubation with bacteria, 
but what is expected is that the relations between the different cell 
experiments should be consistent and persistent within the 3 runs of the 
FACS analyses.  
The fluctuating nature of the cell growth and proliferation, as well as the one 
week time interval between each FACS analysis, may be regarded as good 
explanations for the high values of the standard deviations of the averages 
which were obtained from the three successive FACS analyses. However, the 
results that were obtained from the three FACS analyses, regarding the 
relations between the different cell experiments and the controls, were found 
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to be consistent with each other, and with those results obtained from the cell 
counting with the Cellometer (Figure 8). 
 




Total positive % 
for the ki-67  
Total positive % 




% after omitting 
the % of the 2ry 
antibody 
AA1 39.46%  1.49%  37.97% 
AA100 26.26%  1.45% 24.81% 
EC1 35.53%  1.53% 34% 
EC100 28.50%  1.26% 27.24% 
Control  19.13%  1.36% 17.77% 
 
Table 2: Showing the MSCs positive percentage for ki-67 after sorting with the 
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Total positive % 
for the ki-67  
Total positive % 
for the isocontrol 
(2ry antibody 
only)  
Total positive % 
after omitting 
the % of the 2ry 
antibody 
AA1 64.50%  2.67%  61.83% 
AA100 52.87%  2.13% 50.74% 
EC1 46.12%  2.00% 44.12% 
EC100 41.05%  3.52% 37.53% 
Control  33.67%  1.06% 32.61% 
 
Table 3: Showing the MSCs positive percentage for ki-67 after sorting with the 
FACS analysis (the second FACS analysis), after 67 days of incubation with 
the bacteria. 




Total positive % 
for the ki-67  
Total positive % 
for the 
isocontrol (2ry 
antibody only)  
Total positive % 
after omitting 
the % of the 2ry 
antibody 
AA1 66.63%  6.77%  59.86% 
AA100 58.63%  1.33% 57.3% 
EC1 77.12%  5.19% 71.93% 
EC100 78.01%  6.59% 71.42% 
Control  57.73%  3.69% 54.04% 
 
Table 4: Showing the MSCs positive percentage for ki-67 after sorting with the 
FACS analysis (the third FACS analysis), after 74 days of incubation with the 
bacteria. 








Figure 8: The averages and the standard deviations of the three successive 
FACS analyses of the MSCs for the ki-67 antibody, after 74 days of incubation 
with bacteria with different ratios.  
 
 








Figure 9: The FACS analysis of the AA1 cells for the ki-67 after 60 days of 
incubation with the bacteria. Figure 9a: The negative control experiment, 
where the R1 region represents the dot plot of the whole MSCs population 
resulting from light scattering (side scatter versus forward scatter), R2 region 
represents the dot plot of the ki-67 unlabeled (negative) stem cell population 
gated from the R3 region, which represents the positive stem cell population 
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labeled with ki-67 antibody (FITC). Figure 9b: The isocontrol experiment (only 
2ry anti-mouse antibody). Figure 9c: The cell sorting of the AA1 cells for the ki-
67 antibody, where the green dot plot represents the negative unlabeled cell 
population (R2), and the blue dot plot represents the positive stem cell 
population labeled with ki-67 antibody (FITC)(R3).    
 
 
Figure 10a                                 Figure 10b 
Figure 10a:  The cell sorting of the EC1 cells for the ki-67 antibody after 60 
days of incubation with the bacteria, where the green dot plot represents the 
negative unlabeled cell population (R2), and the blue dot plot represents the 
positive stem cell population labeled with ki-67 antibody (FITC)(R3). 
Figure10b: The cell sorting of the EC100 cells for the ki-67 antibody, where 
the green dot plot represents the negative unlabeled cell population (R2), and 
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Figure 11a                                     Figure 11b 
Figure 11a:  The cell sorting of the AA100 cells for the ki-67 antibody after 60 
days of incubation with the bacteria, where the green dot plot represents the 
negative unlabeled cell population (R2), and the blue dot plot represents the 
positive stem cell population labeled with ki-67 antibody (FITC)(R3). 
Figure11b: The cell sorting of the control experiment cells for the ki-67 
antibody, where the green dot plot represents the negative unlabeled cell 
population (R2), and the blue dot plot represents the positive stem cell 
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3.2 Testing the cells for stem cell markers after 
incubation with bacteria 
 
3.2.1 Testing the cells for the stem cell markers 
(CD44, CD29, CD166, and CD105) with the 
immunohistochemistry after three weeks of 
incubation with bacteria 
 
After 3 weeks of incubation with the Actinobacillus actinomycetemcomitans 
and the Eikenella corrodens, the MSCs were tested for the stem cell markers 
which have been used for their identification as stem cells by Böcker et al. in 
2008. The cells in the five different experiments (AA1, AA100, EC1, EC100, 
and the control) were checked for the CD44, CD29, CD166, and CD105 
markers with the immunocytochemistry. All the MSCs showed positive 
reactions for the four stem cell markers indicating that the cells still preserved 
their stemness after 3 weeks of incubation with bacteria (Figures 12, 13, 14, 
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                       Figure 12                                         Figure 13 
Figure 12: Staining of the AA1 cells with immunohistochemistry indicating a 
positive reaction for the CD44 antibody (PE) after 3 weeks of incubation with 
bacteria. Figure 13: Showing the negative control of the AA1 cells for the 
CD44 antibody. 
 
     
Figure 14                                        Figure 15 
Figure 14: Staining of the AA100 cells with immunohistochemistry indicating a 
positive reaction for the CD166 antibody (FITC) after 3 weeks of incubation 
with bacteria. Figure 15: Staining of the EC1 cells with immunohistochemistry 
indicating a positive reaction for the CD29 antibody (PE) after 3 weeks of 
incubation with bacteria. 
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Figure 16                                       Figure 17 
Figure 16: Staining of the EC100 cells with immunohistochemistry, indicating 
a positive reaction for the CD105 antibody (FITC) after 3 weeks of incubation 
with bacteria. Figure 17: Staining of the control cells with 
immunohistochemistry indicating a positive reaction for the CD44 antibody 
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3.2.2 Testing the MSCs for the stemness markers 
(Klf4 and C-myc) genes and their associated effects 
on the osteogenic genes (Runx2 and Col1) using the 
real time PCR after 2 months of incubation with 
bacteria 
 
After two months of incubation with the bacteria, the stemness markers have 
been tested with the real time PCR.  
 
3.2.2.1 Isolation of the RNA from the cells 
 
The amounts of the RNA that have been isolated from the five different cell 
experiments were measured with the NanoDrop apparatus, and the following 
results were obtained (Table 5, Figure 18). 
Cell experiment Amount of the RNA 
isolated in ng/µl 
AA1 635.7 ng/µl  
AA100 275.5 ng/µl 
EC1 195.3 ng/µl 
EC100 381.4 ng/µl 
Control 358.9 ng/µl 
 
Table 5: The measurements of the amounts of RNA that have been isolated 
from the five different cell experiments after 2 months of incubation with 
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Figure 18: The NanoDrop apparatus measurement of the amount of the RNA 
isolated from the AA1 cells, after 2 months of incubation with Actinobacillus 
actinomycetemcomitans bacteria with 1:1 ratio.  
 
3.2.2.2 Efficiency of the primers  
 
Efficiency of the primers (E) have been determined applying different dilution 
factors (1:1, 1:5, 1:10, and 1:15) of the target cDNA. Real time PCR was then 
performed for the different dilutions, and the efficiency of the primers were 









Figure 19: Efficiency curve of the Klf4 primer with the different dilution factors 
of the cDNA obtained from the AA1 cells after 2 months of incubation with 
bacteria, whereas the x-axis values are the logarithms of the different dilutions 
of the cDNA and the y-axis values are the averages of the Ct values.  
 
3.2.3 Determination of the relative expression of the 
stemness markers (Klf4 and C-myc) genes and their 
associated effects on the osteogenic genes (Runx2 and 
Col1) after bacterial induction 
 
To determine whether a gene is up or down regulated, the equation in Figure 
20 was used according to the Pfaffl model (Pfaffl 2001). The Pfaffl model is a 
mathematical model that was presented to determine the relative 
quantification of a target gene in comparison to a reference (housekeeping) 
gene. The relative expression ratio of the target is first calculated based on 
the efficiency and the Ct deviation (ΔCt) values of the treated sample (cells 
incubated with bacteria) versus a control sample (the control cells), then 
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expressed in comparison to a reference gene (β2M). The β2M, which is one 
of the housekeeping genes, has been found and proved to be unregulated 
under the different experimental conditions applied in this study (long periods 
of incubation with bacteria), and therefore, the β2M has been used as a 
reference gene to which the inspected genes (C-myc, Runx2, Klf4, and Col1) 
have been normalized in order to determine their relative expression ratios 




Figure 20: Pfaffl equation, where the Etarget is the efficiency of the target gene, 
Eref is the efficiency of the reference gene (β2M), ΔCt target is the Ct deviation 
of control – treated sample of the target gene, and ΔCt ref is the Ct deviation 
of control – treated sample of the reference gene (β2M). According to this 
equation, the relative expression ratios of the different genes have been 
calculated.  
According to the Pfaffl model, and the Pfaffl relative expression software tool 
(REST), the values that will be obtained from the equation will be either 
positive or negative. So if the value that will be obtained from the equation is 
+2, this means that the target gene is over expressed by 2 folds in the treated 
sample, when being compared to its original expression in the control sample, 
and if the value that will be obtained from the equation is -1, this means that 
the target gene is under expressed by 1 fold in the treated sample, when 
being compared to its original expression in the control sample (Pfaffl 2001, 
Pfaffl et al. 2002). 
The results that were obtained with the C-myc and the Klf4 by the real time 
PCR were highly significant. All of the 4 different cell experiments (incubated 
with bacteria) showed up-regulation for the C-myc and the Klf4 genes after 
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the 2 months of bacterial incubation (Figures 21 and 22). It was also noticed 
that the EC100 cells always exhibited the highest relative expression ratios for 
both C-myc and Klf4 genes when compared to the cells in the other 
experiments. The effects of the bacterial incubation on the osteogenic 
markers (Runx2 and Col1 genes) were also determined by the real time PCR. 
The previous results that were obtained with the Klf4 and the C-myc genes 
were found to be matching with those obtained with the Runx2 and the Col1 
genes, whereas all the different cell experiments showed up-regulation for 
both Runx2 and Col1 genes (Figures 23 and 24), and significantly, and as in 
the case of Klf4 and C-myc, the EC100 cells always exhibited the highest 
relative expression ratios when compared with the cells in the other 
experiments. There is no certain explanation for the always high relative 
expression ratios in the case of EC100 cells, but it may be relevant to the 
number of the bacterial colonies, and the degree of bacterial virulence. The 
up-regulation of the genes responsible for stemness, and its significant effect 
on the up-regulation of the osteogenic genes in response to incubation with 
periodontal pathogens, supports the idea of the usage of the BMSCs as a 
preferable stem cell source for achieving complete stem cell based 
regeneration of the alveolar bone resorption that is associated with the 
periodontal disease.  
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Figure 21: The relative expression ratios of the C-myc gene in the 4 different 
cell experiments after 2 months period of incubation with bacteria. The C-myc 
relative expression ratios were normalized to the expression levels of the 
β2M. 
 
Figure 22: The relative expression ratios of the Klf4 gene in the 4 different cell 
experiments after 2 months period of incubation with bacteria. The Klf4 
relative expression ratios were normalized to the expression levels of the 
β2M. 
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Figure 23: The relative expression ratios of the Runx2 gene in the 4 different 
cell experiments after 2 months period of incubation with bacteria. The Runx2 
relative expression ratios were normalized to the expression levels of the 
β2M. 
 
Figure 24: The relative expression ratios of the Col1 gene in the 4 different 
cell experiments after 2 months period of incubation with bacteria. The Col1 
relative expression ratios were normalized to the expression levels of the 
β2M. 
   3 Results 
 61 
3.3 Testing the MSCs for the osteogenic 
differentiation after the incubation with the 
osteogenic differentiation medium 
 
After 2 months of incubation of the cells with bacteria, the cells were then 
transferred to the osteogenic differentiation medium. Cells were divided into 2 
main groups: 
1. Cells which were osteodifferentiated with mesenchymal stem cell 
osteogenic differentiation medium (Promocell GmbH, Heidelberg, 
Germany). The cells in this group were given the names (O-AA1-, O-
AA100-, O-EC1-, O-EC100-, and O-control). 
 
2. Cells which were osteodifferentiated with mesenchymal stem cell 
osteogenic differentiation medium and with the addition of the bacteria 
to the osteogenic differentiation medium with the same previous ratios 
of incubation (1:1 and 1:100). The cells in this group were given the 
names (O-AA1+, O-AA100+, O-EC1+, and O-EC100+). 
 
 (O-AA1+) with 1 bacterial colony (AA):1 cell. 
 (O-AA100+) with 1 bacterial colony (AA):100 cells. 
 (O-EC1+) with 1 bacterial colony (EC):1 cell. 
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3. Thus finally 9 different cell experiments were obtained:  
 1. O-AA1+ 
2. O-AA100+       osteogenic differentiation medium                                  
3. O-EC1+                        with bacteria (+). 
4. O-EC100+ 
 
 5. O-AA1- 
6. O-AA100- 
7. O-EC1-            osteogenic differentiation medium                        
8. O-EC100-                     without bacteria (-).                                             
9. O-control 
 
3.3.1 Alkaline phosphatase staining 
 
After 8 days of the incubation of the MSCs within the osteogenic 
differentiation medium, cells were checked for the alkaline phosphatase 
enzyme activity. In all of the 9 different cell experiments positive reactions for 
the alkaline phosphatase were obtained for approximately 90% of the 
investigated cells (Figures 25, 26, 27, 28, 29, 30, 31, 32, 33, and 34).   
      
Figure 25                                              Figure 26 
Figure 25: Alkaline phosphatase staining for the (O-EC1-) cells after 8 days of 
incubation with the osteogenic differentiation medium without bacterial 
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addition. Figure 26: Alkaline phosphatase staining for the (O-AA1-) cells after 
8 days of incubation with the osteogenic differentiation medium without 
bacterial addition. 
 
        
Figure 27                                              Figure 28 
Figure 27: Alkaline phosphatase staining for the (O-EC1+) cells after 8 days of 
incubation with the osteogenic differentiation medium with the addition of 
Eikenella corrodens (1:1 ratio). Figure 28: Alkaline phosphatase staining for 
the (O-AA1+) cells after 8 days of incubation with the osteogenic 
differentiation medium with the addition of Actinobacillus 
actinomycetemcomitans (1:1 ratio). 
           
Figure 29                                              Figure 30 
Figure 29: Alkaline phosphatase staining for the (O-EC100-) cells after 8 days 
of incubation with the osteogenic differentiation medium without bacterial 
addition. Figure 30: Alkaline phosphatase staining for the (O-AA100-) cells 
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after 8 days of incubation with the osteogenic differentiation medium without 
bacterial addition. 
 
        
Figure 31                                              Figure 32 
Figure 31: Alkaline phosphatase staining for the (O-EC100+) cells after 8 days 
of incubation with the osteogenic differentiation medium with the addition of 
Eikenella corrodens (1:100 ratio). Figure 32: Alkaline phosphatase staining for 
the (O-AA100+) cells after 8 days of incubation with the osteogenic 
differentiation medium with the addition of Actinobacillus 
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Figure 33                                             Figure 34 
Figure 33: Alkaline phosphatase staining for cells of the O-control experiment 
(no previous 2 months of bacterial incubation) after 8 days of incubation with 
the osteogenic differentiation medium without bacterial addition to the 
medium. Figure 34: The negative control. 
         
3.3.2 Testing the MSCs for the osteogenic 
differentiation with the help of immunocytochemistry  
 
After 12 days of incubation with the osteogenic differentiation medium, the 
cells in the 9 different experiments were checked for osteopontin with the help 
of immunocytochemistry. Osteopontin is an extracellular structural protein, 
and an important component of the bone. It also acts as an indicator of bone 
turnover.  
The MSCs in all of the 9 different experiments (O-AA1+, O-AA1-, O-AA100+, 
O-AA100-, O-EC1+, O-EC1-, O-EC100+, O-EC100-, and O-control) showed 
positive reactions with the osteopontin antibodies (Figures 35, 36, 37, 38, 39, 
40, 41, 42, 43, and 44). 
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Figure 35                                       Figure 36 
Figure 35: Staining of the (O-EC1-) cells with immunohistochemistry, 
indicating a positive reaction for the osteopontin antibody (FITC), after 12 
days of incubation in the osteogenic differentiation medium without bacterial 
addition to the medium. Figure 36: Staining of the (O-AA1-) cells with 
immunohistochemistry, indicating a positive reaction for the osteopontin 
antibody (FITC), after 12 days of incubation in the osteogenic differentiation 
medium without bacterial addition to the medium. 
 
       
Figure 37                                       Figure 38 
Figure 37: Staining of the (O-EC1+) cells with immuno-histochemistry, 
indicating a positive reaction for the osteopontin antibody (FITC), after 12 
days of incubation in the osteogenic differentiation medium of incubation with 
the osteogenic differentiation medium with the addition of Eikenella corrodens 
(1:1 ratio) to the medium. Figure 38: Staining of the (O-AA1+) cells with 
immunohistochemistry, indicating a positive reaction for the osteopontin 
   3 Results 
 67 
antibody (FITC), after 12 days of incubation in the osteogenic differentiation 
medium of incubation with the addition of Actinobacillus 
actinomycetemcomitans (1:1 ratio) to the medium. 
 
        
 Figure 39                                                Figure 40 
Figure 39: Staining of the (O-EC100-) cells with immunohistochemistry, 
indicating a positive reaction for the osteopontin antibody (FITC), after 12 
days of incubation in the osteogenic differentiation medium without bacterial 
addition to the medium. Figure 40: Staining of the (O-AA100-) cells with 
immunohistochemistry, indicating a positive reaction for the osteopontin 
antibody (FITC), after 12 days of incubation in the osteogenic differentiation 
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Figure 41                                             Figure 42 
Figure 41: Staining of the (O-EC100+) cells with immunohistochemistry, 
indicating a positive reaction for the osteopontin antibody (FITC), after 12 
days of incubation in the osteogenic differentiation medium of incubation with 
the osteogenic differentiation medium with the addition of Eikenella corrodens 
(1:100 ratio) to the medium. Figure 42: Staining of the (O-AA100+) cells with 
immunohistochemistry, indicating a positive reaction for the osteopontin 
antibody (FITC), after 12 days of incubation in the osteogenic differentiation 
medium of incubation with the addition of Actinobacillus 
actinomycetemcomitans (1:100 ratio) to the medium. 
 
       
Figure 43                                               Figure 44 
Figure 43: Staining of the cells of the O-control experiment (no previous 2 
months of bacterial incubation) with immunohistochemistry, indicating a 
positive reaction for the osteopontin antibody (FITC), after 12 days of 
incubation in the osteogenic differentiation medium of incubation without 
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bacterial addition to the medium. Figure 44: Showing the negative control of 
the (O-AA1+) cells for the osteopontin antibody. 
 
3.3.3 Testing the MSCs for the degree of osteogenic 
differentiation using the real time PCR (testing the 
expression of the Runx2 and Col1 after osteogenic 
differentiation) 
 
After a period of 2 weeks of incubation with the osteogenic differentiation 
medium, MSCs in the 9 different cell experiments (O-AA1+, O-AA1-, O-
AA100+, O-AA100-, O-EC1+, O-EC1-, O-EC100+, O-EC100-, and O-control) 
were tested for the degrees of osteogenic differentiation using the real time 
PCR. The relative expression ratios of the Runx2 and the Col1 genes were 
calculated according to the Pfaffl model, and the exact degrees of the up or 
the down regulations of the genes were obtained (Figures 45 and 46, Tables 
6 and 7). 
According to the Pfaffl relative expression software tool, the relative 
expression ratios were calculated based on the efficiency and the Ct deviation 
(ΔCt) values of the treated samples (cells incubated with osteogenic 
differentiation medium; O-AA1+, O-AA1-, O-AA100+, O-AA100-, O-EC1+, O-
EC1-, O-EC100+, O-EC100-, and O-control) versus the control samples which 
are the original cell experiments without the incubation with the osteogenic 
differentiation medium, and after the incubation with bacteria (AA1, AA100, 
EC1, EC100, and control cell experiments). According to this, each original 
cell experiment without the incubation with the osteogenic differentiation 
medium will be regarded as a control in the Pfaffl model for 2 cell experiments 
after the incubation with the osteogenic differentiation medium except for the 
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original control cell experiment which will be regarded as a control only for the 
O-control cell experiment, this can be more clarified as following: 
1. AA1 (which is the original AA1 cell experiment after the incubation with 
bacteria and without the incubation with the osteogenic differentiation 
medium) will be used as a control in the Pfaffl equation for the (O-
AA1+) cell experiment (which is the AA1 cell experiment after the 
incubation with osteogenic differentiation medium containing bacteria 
with the 1:1 ratio “+” ) and for the (O-AA1-) cell experiment (which is 
the AA1 cell experiment after the incubation with osteogenic 
differentiation medium that does not contain bacteria “–“ ). 
2. AA100 (which is the original AA100 cell experiment after the incubation 
with bacteria and without the incubation with the osteogenic 
differentiation medium) will be used as a control in the Pfaffl equation 
for the (O-AA100+) cell experiment (which is the AA100 cell experiment 
after the incubation with osteogenic differentiation medium containing 
bacteria with the 1:100 ratio “+” ) and for the (O-AA100-) cell 
experiment (which is the AA1 cell experiment after the incubation with 
osteogenic differentiation medium that does not contain bacteria “–“ ). 
3. EC1 (which is the original EC1 cell experiment after the incubation with 
bacteria and without the incubation with the osteogenic differentiation 
medium) will be used as a control in the Pfaffl equation for the (O-
EC1+) cell experiment  (which is the EC1 cell experiment after the 
incubation with osteogenic differentiation medium containing bacteria 
with the 1:1 ratio “+” ) and for the (O-EC1-) cell experiment (which is 
the EC1 cell experiment after the incubation with osteogenic 
differentiation medium that does not contain bacteria “–“ ). 
4. EC100 (which is the original EC100 cell experiment after the incubation 
with bacteria and without the incubation with the osteogenic 
differentiation medium) will be used as a control in the Pfaffl equation 
for the (O-EC100+) cell experiment (which is the EC100 cell 
experiment after the incubation with osteogenic differentiation medium 
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containing bacteria with the 1:100 ratio “+” ) and for the (O-EC100-) 
cell experiment (which is the EC100 cell experiment after the 
incubation with osteogenic differentiation medium that does not contain 
bacteria “–“ ). 
5. The control cell experiment (which is the original control cell experiment 
in which the cells were not incubated with bacteria at all in the first 
experiment and without incubation with osteogenic differentiation 
medium in the second experiment) will be used as a control in the Pfaffl 
equation for the (O-control) cell experiment (the original control cell 
experiment that was not incubated with bacteria at all, and after the 
incubation with osteogenic differentiation medium that does not contain 
bacteria). 
Therefore, and according to what was explained previously, the relative 
expression ratios were calculated based on the efficiency and the Ct deviation 
(ΔCt) values of treated samples (cells incubated with osteogenic 
differentiation medium; O-AA1+, O-AA1-, O-AA100+, O-AA100-, O-EC1+, O-
EC1-, O-EC100+, O-EC100-, and O-control) versus control samples which 
are the AA1 cell experiment (as a control for O-AA1+, O-AA1-), the AA100 cell 
experiment (as a control for O-AA100+, O-AA100-), the EC1 cell experiment 
(as a control for O-EC1+, O-EC1-), the EC100 cell experiment (as a control 
for O-EC100+, O-EC100-), and the control cell experiment (as a control for O-
control), then they were expressed in comparison to a reference gene (β2M). 
The β2M, which is one of the housekeeping genes, has been found and 
proved to be unregulated under the different experimental conditions applied 
in this case study (incubation with the osteogenic differentiation medium for 2 
weeks), and therefore, the β2M has been used as a reference gene to which 
the inspected genes (Runx2, and Col1) have been normalized in order to 
determine their relative expression ratios after the incubation with the 
osteogenic differentiation medium according to the Pfaffl equation.   
Interestingly, the MSCs in all the nine different cell experiments showed up-
regulation of the two genes (Runx2 and Col1) enforcing the results obtained 
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by the immunohistochemistry and the alkaline phosphatase staining. 
Relations between the relative expression ratios of the MSCs in the different 
experiments were significant. For the cells incubated with the Actinobacillus 
actinomycetemcomitans, the (O-AA1+) cells always exhibited the lowest 
relative expression ratios, while the (O-AA100+) cells always exhibited the 
highest relative expression ratios (+9.56 with Runx2 and +5.73 with Col1). 
The cells in all of the different Actinobacillus actinomycetemcomitans cell 
experiments (O-AA1-, O-AA100-, and O-AA100+) exhibited higher relative 
expression ratios than the cells in the (O-control) experiment except for the 
(O-AA1+) cells which exhibited lower relative expression ratio than the (O-
control) cells. These results were found to be consistent with both of the Col1 
and Runx2 genes. For the cells incubated with the Eikenella corrodens, the 
relations between the relative expression ratios were not the same with the 
Col1 and Runx2 genes. In the case of Runx2, only the (O-EC100+) cells 
showed relative expression ratio (+2.81) higher than the O-control cells 
(+1.907), while the rest of the cells in the different experiments showed 
relative expression ratios lower than those obtained from the (O-control) cells. 
Results with the Col1 were significantly different from those obtained with the 
Runx2, the (O-EC1-) cells showed an extremely high relative expression ratio 
(+6.56) when compared with the (O-control) cells (+1.32). The relative 
expression ratios obtained from the cells in the rest of the EC cell experiments 
(O-EC1+, O-EC100-, and O-EC100+) were lower than those obtained from 
the (O-control) cells. The (O-EC1+) cells always showed the lowest relative 
expression ratios with both of the Col1 and Runx2 genes. It may be possible 
that the addition of high numbers of bacteria (1:1 ratio) with the osteogenic 
differentiation medium, may have affected the chemical composition of the 
differentiation medium, resulting in the decrease of the osteogenic 









The relative expression ratio 
value 
The standard deviation of the 
relative expression ratios 
O-EC1- +1.79967448 0.31039898 
O-EC1+ +0.67108686 0.08788627 
O-EC100- +1.26826805 0.19793847 
O-EC100+ +2.81047034 0.35030524 
O-AA1- +2.51028463 0.34639867 
O-AA1+ +0.64786158 0.10575723 
O-AA100- +7.00519082 0.49586518 
O-AA100+ +9.56186163 1.3003321 




Table 6 and Figure 45: The relative expression ratios of the Runx2 gene in the 
9 different cell experiments (O-AA1+, O-AA1-, O-AA100+, O-AA100-, O-
EC1+, O-EC1-, O-EC100+, O-EC100-, and O-control), after 2 weeks of 
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incubation in the osteogenic differentiation medium. The Runx2 relative 





The relative expression 
ratio value 
The standard deviation of the 
relative expression ratios 
O-EC1- 6.56452552 0.39405914 
O-EC1+ 0.57095362 0.05823776 
O-EC100- 0.63584312 0.10521236 
O-EC100+ 0.28422853 0.0374514 
O-AA1- 1.96580938 0.4641293 
O-AA1+ 0.22749373 0.03975667 
O-AA100- 1.53548708 0.2148489 
O-AA100+ 5.73755289 0.48272046 
O-control 1.32680252 0.28164993 
 
Table 7: The relative expression ratios of the Col1 gene in the 9 different cell 
experiments (O-AA1+, O-AA1-, O-AA100+, O-AA100-, O-EC1+, O-EC1-, O-
EC100+, O-EC100-, and O-control), after 2 weeks of incubation in the 
osteogenic differentiation medium. The Col1 relative expression ratios were 
normalized to the expression levels of the β2M. 
 




Figure 46: The relative expression ratios of the Col1 gene in the 9 different 
cell experiments (O-AA1+, O-AA1-, O-AA100+, O-AA100-, O-EC1+, O-EC1-, 
O-EC100+, O-EC100-, and O-control), after 2 weeks of incubation in the 
osteogenic differentiation medium. The Col1 relative expression ratios were 
normalized to the expression levels of the β2M. 
 




Periodontal diseases are the main cause of tooth loss. They constitute a 
substantial public health burden worldwide. Approximately, two thirds of 
German citizens suffer from periodontitis (Morsczeck et al. 2008). These 
periodontal diseases are characterized by the destruction of the periodontal 
supporting tissues including PDL, cementum, alveolar bone, and gingiva (Tan 
et al. 2009, Zhao et al. 2008). Periodontitis is initiated by bacterial colonization 
of the surfaces of the teeth in the region of the gingival sulcus and further 
extension of the bacterial plaque apically. Bacteria ingress themselves 
between the gingival tissues and the root surface to result in the extensive 
inflammation, pocket formation, and destruction of the soft tissue and the 
alveolar bone housing the root surfaces of the teeth (Srinivas et al. 2012). It is 
believed that most of the destruction of the soft and hard tissues of the 
periodontium is a result of the activation of the host-immune inflammatory 
response to the bacterial challenge (Offenbacher 1996). Offenbacher stated 
that, “the periodontopathic bacterial flora is necessary but not sufficient for 
disease” (Offenbacher 1996), stressing in his study, that was carried out in 
1996, on the major role of the host-immune inflammatory response, rather 
than the bacterial role in the progressive and destructive nature of the 
disease.  
More and more studies began to consider BMSCs as a preferable cell source 
for periodontal regeneration (Mizuno et al. 2008, Donzelli et al. 2007, George 
et al. 2006). Kawaguchi et al. autotransplanted BMSCs into experimental 
periodontal class III defects in beagle dogs, and found that the defects in the 
test group were regenerated with cementum, PDL, and alveolar bone. The 
transplanted BMSCs were found to be differentiated into various connective 
tissue cells in vivo under the influence of certain host factors. This influence of 
the local microenvironment on the BMSCs to differentiate into various 
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specialized functional cells is a process known as site-specific differentiation 
of BMSCs (Krause et al. 2001, Quintavalla et al. 2002, Kawaguchi et al. 
2004). A similar study was carried out by Hasegawa et al. in which the MSCs 
were labeled with green fluorescence protein (GFP), expanded in vitro, and 
then transplanted into experimental class III defects. After four weeks of 
transplantation, the periodontal defects were found to be almost completely 
regenerated with osteoblasts, osteocytes, and cementoblasts that were 
positive with the GFP when evaluated by immunohistochemical analysis 
(Hasegawa et al. 2006). Another study that was performed by Yang et al. on 
Sprague Dawley (SD) rats showed that; the experimental periodontal surgical 
defects that were regenerated with the BMSCs showed more appropriately 
oriented PDL fibers when compared to the control groups. Yang et al. 
transplanted rat BMSCs that were expanded in vitro on microcarrier gelatin 
beads, into surgically created periodontal defects. After three weeks of 
transplantation, histological evidences showed that the area of regenerated 
alveolar bone in the animals that received the cells and the bead-transplants 
were significantly larger than the area of regenerated alveolar bone in the 
control animals. Moreover, the PDL fibers that were regenerated in the 
animals that received the BMSCs gelatin beads showed more preferable 
perpendicularly oriented Sharpey’s fibers (the PDL fibers that are inserted into 
the cementum), than the control groups, that showed disorganized 
nonfunctional regenerated Sharpey’s fibers (Yang et al. 2010, Shimono et al. 
2003). 
On these bases, and according to the hypothesis of Offenbacher; concern in 
this study was mainly directed to elucidate the effects of the periodontopathic 
bacteria on the behavior of the MSCs regarding their stemness, degree of 
osteogenic differentiation, and proliferation capacity. 
The human ki-67 is a protein that is associated with cell proliferation. Gerdes 
et al. were the first to prove that the ki-67 antigen is present only in the 
proliferating cells and absent in the resting cells. Gerdes demonstrated that 
when the resting cells were transformed into proliferating cells, for example, 
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stimulation of the lymphocytes with phytohemagglutinin A (PHA), the ki-67 
antigen was found to be apparent only in the nuclei of the proliferating cells, 
and absent from the nuclei of the non-stimulated resting lymphocytes. On the 
other hand, the ki-67 antigen disappears when the proliferating cells are 
induced to differentiate into resting cells (Gerdes et al. 1983, 1984). During 
the interphase, the ki-67 is detected only in the nucleus, and the protein is 
found to be present during all active phases of the cell cycle, but is absent 
from the resting cells, making it an excellent marker for determining the 
growth fraction and the proliferation rate of a given cell population (Kannan et 
al. 1996, Sittel et al. 1999).  
Regarding the MSCs proliferation, this present study has shown that the cell 
numbers in most of the cell counts (with the Cellometer), and the expression 
of the ki-67 protein within the cells were increased linearly with the increased 
numbers (ratios) of the periodontopathic bacteria that were incubated with the 
cells. These findings were found to be consistent with the findings that were 
presented by MacNamara et al. in 2011. MacNamara, who worked on 
hematopoietic stem cells, demonstrated that the progenitor cells undergo a 
transition from a dormant state to an active state, and exhibit increased 
proliferation during in vivo bacterial infection with Ehrlichia muris (MacNamara 
et al. 2011). Although the non-hematopoietic stem cells differ from the 
hematopoietic stem cells, many studies suggested that they both exhibit a 
very close similar reaction to infection and injury (Morsczeck et al. 2008, 
Jones and McGonagle 2008). The same findings were also presented by 
Scumpia et al. who also stated that bacterial infection is a potent activator of 
hematopoietic stem and progenitor cell (HSPC) proliferation and expansion. 
Scumpia injected (intraperitoneal or i.p. injection) mutant mice with the 
lipopolysaccharides of the Escherichia coli, and according to his findings he 
proposed that the bacterial lipopolysaccharides are not only potent activators 
of the HSPC proliferation in vitro, but can also induce the same potent 
activation of HSPC proliferation in vivo (Scumpia et al. 2010). Another study, 
that was performed by Buchon et al. in 2010 also revealed a massive 
increase in the intestinal stem cell proliferation in the adult midgut of 
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Drosophila (which is fairly similar to the gut of mammals), following the 
ingestion of a non-lethal pathogenic bacterium (Erwinia carotovora carotovora 
15). The mammalian intestinal stem cells proliferate continuously to achieve a 
complete turnover of the gut every 3 to 4 days (Potten et al. 1992). Similarly, 
the Drosophila adult midgut contains a group of intestinal stem cells that also 
maintain its turnover integrity by producing a population of undifferentiated 
daughter cells that are termed enteroblasts (Ohlstein and Spradling 2006). 
Buchon et al. demonstrated in their study that was carried out in 2010 that in 
response to the ingestion of a non-lethal pathogenic bacterium, Erwinia 
carotovora carotovora 15, a dramatic remodeling of the Drosophila midgut 
occurs in order to repair a great loss of nearly its half cells’ population. This 
dramatic remodeling and repair occurs through the immediate differentiation 
of the daughter enteroblasts, and through a massive increase in the 
proliferation of the intestinal stem cells (Buchon et al. 2010). Takemura who 
worked on the human periodontal ligament fibroblasts (HPLF), showed that in 
vitro responsiveness of the HPLF to the platelet derived growth factor 
(PDGF)-BB, a growth factor for mesenchymal stem cells, was highly improved 
with the presence of the lipopolysaccharides of Porphyromonas gingivalis. 
Takemura stated that, the Porphyromonas gingivalis lipopolysaccharides 
stimulate the cellular proliferation, and enhance the responsiveness of the 
cultured HLPF to the PDGF-BB factor (Takemura et al. 1998). 
Findings of all of these previous studies support the idea of the increase in the 
stem cell proliferation in response to bacterial insult, and thus enforcing the 
results that were obtained from this present study regarding the elevated 
MSCs’ proliferation levels with the increase in the numbers of the 
periodontopathic bacteria that were incubated with them. 
Regarding the MSCs’ stemness, the main concern in this study was to confirm 
that the MSCs still preserved their stemness after the two months of 
incubation with the periodontopathic bacteria. Böcker et al. who first 
introduced this immortalized hTERT hMSCs (SCP-1) cell line, showed 
positive reactions of these MSCs for the CD166, CD105, CD44, and CD29 
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stem cell markers. Findings in this study showed that the MSCs were still able 
to demonstrate positive reactions with the same stem cell markers indicating 
that they still preserved their stemness after the incubation with the 
periodontopathic bacteria. To confirm these results, and to elucidate the exact 
effect of the bacterial incubation on the stemness of the cells, the MSCs were 
tested for relative expressions of the Klf4 and C-myc genes. 
Many studies sought to reprogram somatic cells towards pluripotency 
(Takahashi and Yamanaka 2006, Cowan et al. 2005, Hansis et al. 2004, 
Alberio et al. 2006, Rodolfa and Eggan 2006). Lewitzky and Yamanaka 
reported that exogenous expression of sox2, oct4, klf4, and c-myc genes into 
somatic cells can reprogram them to give rise to cells with similarity to 
pluripotent cells, and thus they hypothesized that these genes are involved in 
the maintenance of the pluripotency of the stem cells. Another study perfomed 
by Sommer et al. reported the use of a single lentiviral vector expressing the 
four transcription factors c-myc, klf4, oct4, and sox2 in a single lentiviral stem 
cell cassette. All of the reprogrammed cells would receive the four factors 
accomplishing highly efficient induced pluripotent stem cells. This overcomes 
the problem that may occur during multiple viral integrations, as many of the 
reprogrammed cells may receive only one, two, or three factors, making it 
difficult to produce a homogenous population of induced pluripotent stem cells 
(Sommer et al. 2009).     
The c-myc gene belongs to a family of helix-loop-helix/leucine zipper 
transcription factors. C-myc is associated with a number of cellular functions 
including cell growth, differentiation, proliferation, and transformation. The c-
myc has been proposed as a major factor that supports the maintenance of 
pluripotency (Lewitzy and Yamanaka 2007, Cartwright et al. 2005). The 
potential role of c-myc in the maintenance of the pluripotency in the stem cells 
is suggested by two reports. First, expression of an RLF/L-myc minigene, that 
delays the stem cells’ differentiation and interferes with early embryonic 
development (MacLean-Hunter et al. 1994). Second, elevated c-myc activity 
is able to block the differentiation of multiple cell lineages (Selvakumaran et 
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al. 1996, Canelles et al. 1997, Pelengaris et al. 1999, Schreiner et al. 2001, 
Knoepfler et al. 2002).  
Smith et al. who worked on induced pluripotent stem cells, through the 
exogenous expression of sox2, oct4, and klf4 genes into mouse embryionic 
fibroblasts, according to the Takahashi and Yamanaka model in 2006, 
proposed that the c-myc has an important direct effect on repressing the 
expression of GATA6, which is a master regulator of primitive endoderm 
formation (Morrisey et al. 1998, Koutsourakis et al. 1999), and, therefore, they 
suggested that the c-myc plays an important role in the maintenance of 
pluripotency. Smith et al. hypothesized that the repressing effect applied by 
the c-myc on the GATA6 may have a transcriptional control basis, as the myc-
family-regulated miRNAs could potentially impact on the GATA6 translation. 
Smith also demonstrated that the loss of the c-myc and n-myc results in 
preferential differentiation of the induced pluripotent stem cells towards 
primitive endoderm (Smith et al. 2010). 
Li et al. suggested that the klf4 acts as an inhibitor for the embryonic stem cell 
differentiation. The same suggestion was demonstrated by Lewitzky and 
Yamanaka who hypothesized that the overexpression of the klf4 leads to 
sustained expression of oct4 and inhibition of the differentiation in the 
embryonic stem cells. Klf4 also acts as a major downstream target for the             
LIF/STAT3 pathway, helping in maintaining the pluripotency of the embryonic 
stem cells (Li et al. 2005, Lewitzky and Yamanaka 2007). 
This study showed that the relative expression ratios of the Klf4, and the C-
myc genes were increased in response to bacterial induction indicating that 
the MSCs not only preserved their stemness after incubation with bacteria, 
but also improved their stemness potential as well. Although this may 
contradict common sense at first glance, the consistency and the persistence 
of the relations between the relative expression ratios for both of the 
stemness genes (Klf4 and C-myc) within the four cell experiments           
(AA1, AA100, EC1, and EC100) enforces the previously obtained results. 
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Regarding the capability of the MSCs to show osteogenic differentiation after 
the two months of incubation with the periodontopathic bacteria, findings of 
this study revealed that the MSCs were still able to produce positive reactions 
with the alkaline phosphatase staining after eight days of incubation in the 
osteogenic differentiation medium indicating that the MSCs still preserved 
their osteogenic character after the bacterial incubation. 
Alkaline phosphatase is a glycoprotein that belongs to a family of proteins 
anchored to the plasma membrane via glycosylphosphatidylinositol linkages. 
It was found to act as a catalyst for the hydrolysis of phosphate esters in 
alkaline pH (Leung et al. 1993). Dziak, in 1992, stated that the alkaline 
phosphatase must be membrane-bound to start the mineralization process 
from solutions containing physiological concentrations of calcium and 
phosphate (Piattelli et al. 1996). Alkaline phosphatase is a common 
biochemical marker that is used to assess osteoblast differentiation and is 
considered to be involved in skeletal mineralization (Leung et al. 1993, 
Piattelli et al. 1996). Alkaline phosphatase was also found to be abundant in 
matrix vesicles which play an important role in extracellular matrix processing 
and calcification of bone (Harris 1990). Bellows et al. have shown that the 
levels of the alkaline phosphatase are increased just before mineralization is 
initiated. Despite the fact that the exact role of alkaline phosphatase in 
mineralization remains unclear, as it is widely distributed in all mammalian 
tissues, it still has important functions that are highly helpful to the 
mineralization process, as it is involved in the calcium-binding action, the 
generation of free phosphate, and the degradation of mineralization inhibitors 
(Bellows et al. 1991, Piattelli et al. 1995, 1996).  
In order to confirm the results that were obtained with the alkaline 
phosphatase staining, the MSCs were checked for osteopontin occurrence 
with the help of immunohistochemistry. Osteopontin is an adhesive 
glycoprotein specifically localized in the mineralized extracellular matrix of 
bone and synthesized primarily by osteoblasts, endothelial cells and 
megakaryocytes (Wendel et al. 1998). Hultenby et al. stated that the 
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osteopontin was found to be enriched at the mineralization front, and 
therefore they hypothesized its involvement in mineral deposition and growth. 
Osteopontin is one of the major non-collagenous proteins of bone which plays 
an important role in the regulation of bone mineralization; since it promotes 
the deposition of calcium phosphate (Martinez and Araujo 2004, Hultenby et 
al 1991), and regulates the growth of the hydroxyapatite crystals (Steitz et al. 
2002). Reinholt et al. stated that osteopontin is crucially involved in anchoring 
osteoclasts to the mineral matrix of bone surfaces indicating that it is not only 
involved in mineral deposition, but generally implicated in the bone 
remodeling process (Reinholt et al. 1990). Another more recent study that 
was performed by Thurner et al. showed that the bone quality in osteopontin 
deficient mice was highly affected when compared to the wild types. Thurner 
revealed that osteopontin deficiency causes a 30% decrease in the fracture 
resistance of the bone (Thurner et al. 2010). 
This study demonstrated that all the different cell experiments (O-AA1+, O-
AA1-, O-EC1+, O-EC1-, O-AA100+, O-AA100-, O-EC1+, O-EC1-, O-control) 
showed positive immunohistochemical reactions for the osteopontin indicating 
and enforcing the osteogenic differentiation potential of the cells. 
To elucidate the exact effects of the bacterial incubation on the osteogenic 
character of the MSCs, and to confirm the previous findings obtained from the 
alkaline phosphatase staining, and the immunohistochemical staining for 
osteopontin; cells in the different experiments were tested for the relative 
expression ratios of the osteogenic Runx2, and Col1 genes. 
In vitro, the MSCs can be directed to the osteogenic differentiation lineage in 
the presence of β-glycerophosphate, ascorbic acid, and dexamethasone 
(Pittenger et al. 1999, Beresford et al. 1994). This process is regulated 
through the parallel and sequential expression of lineage specific genes. One 
of the most important transcription factors controlling this process is the 
Runx2 (Shui et al. 2003). Runx2 was found to be sufficient and necessary to 
direct the MSCs towards the osteoblastic lineage (Ziros et al. 2008). During 
the osteoblast differentiation Runx2 up-regulates the expression of bone 
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matrix protein genes including Col1, Spp1, Ibsp, Bglap, and Fn1 and activates 
many promotors including those of Col1, Spp1, Bglap, and MMP-13 (Komori 
2010). As the Runx2 induces the expression of major bone matrix genes in 
osteoblast progenitors, this allows the cells to acquire the osteoblastic 
phenotype while keeping the osteoblastic cells in an immature stage (Komori 
et al. 1997, Komori 2006). According to these concepts, the expressions of 
the Col1, and the Runx2 genes were evaluated with the help of the real time 
PCR in the MSCs of the different cell experiments, and the expression ratios 
were normalized to the expression levels of β2M. 
This study demonstrated that the MSCs in all the different cell experiments 
showed up-regulation for the Runx2 and Col1 genes after being directed to 
the osteogenic lineage enforcing the findings that were obtained with the 
alkaline phosphatase staining and the immunohistochemistry for the 
osteopontin. Regarding the findings that were obtained with the (O-EC1+), 
and the (O-AA1+) cells, as they always showed the lowest relative expression 
ratios with both of the Col1 and Runx2 genes, it may be possible that the 
addition of high numbers of bacteria (1:1 ratio) with the osteogenic 
differentiation medium may have affected the chemical composition of the 
differentiation medium resulting in the decrease of the osteogenic relative 
expression ratios demonstrated by the (O-AA1+) and (O- EC1+) cells. In 
general, and regarding the rest of the results obtained from the real time PCR, 
it can be stated that, with periodontopathogenic bacterial induction a highly 
positive effect of increasing and amplifying the osteogenic character of the 
MSCs can be accomplished.  
Summarizing the findings that were obtained from this study, regarding the 
effects of the periodontopathic bacterial incubation on the proliferation, degree 
of stemness, and osteogenic differentiation of the hMSCs, it can be stated 
that the periodontal pathogenic induction can be used as an enhancing factor 
that can increase the hMSCs proliferation, and can improve and enhance their 
osteogenic differentiation potential at least in vitro.  
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These findings may have a great impact on the stem cell field. Watt and 
Hogen, stated in their review that was published in the Science in 2000 that, 
“Usually between the stem cell and its terminally differentiated progeny there 
is an intermediate population of committed progenitors with limited 
proliferative capacity and restricted differentiation potential, known as 
transient amplifying cells, the primary function of this transient population is to 
increase the number of differentiated cells produced by each cell division. 
This means that, although a stem cell has high self-renewal capacity, it may 
actually divide relatively infrequently” (Watt and Hogen 2000). In this study the 
results suggest that with bacterial induction, increased stem cell proliferation 
can be obtained with preservation of the stemness potential of the cells and 
without the need of differentiation as a mandatory mean to increase the 
numbers of the cells. This means that increasing the frequency of the division 
of the stem cells can be obtained without the need of the stem cell 
differentiation. 
A lot of further research has to be done in order to understand the specific 
mechanism through which the periodontopathic bacteria may contribute to the 
enhancement of the MSCs potential in the regeneration of periodontal 
defects. This will also help in the validation, correlation, and application of 
MSCs in the field of therapeutic stem cell research.  
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5 Summary  
 
For the first time the periodontal pathogens, namely the Actinobacillus 
actinomycetemcomitans, and the Eikenella corrodens were managed to be 
grown in the normal cell culture medium (DMEM). After stopping the growth of 
the bacteria with gentamycin, bacteria were incubated for two months with the 
immortalized hTERT hMSCs with the ratios of 1:1 and 1:100 resulting in five 
different cell-bacteria experiments (AA1, AA100, EC1, EC100, and control). 
Bacterial induction on the MSCs’ proliferation was determined by cell counting 
applying the Cellometer and ki-67 via FACS analysis. The results suggested 
that the higher bacterial numbers (ratios), the higher the proliferation rate of 
the MSCs. During and after the two months of bacterial incubation, the MSCs 
were checked for the effect of bacterial induction in terms of stemness by 
applying immunohistochemistry for the stem cell markers (CD44, CD29, 
CD166, and CD105). Furthermore, real time PCR determined the relative 
expression ratios of the stemness markers C-myc, and Klf4 genes, and their 
effect on the relative expression of the osteogenic Col1, and Runx2 genes. 
Results that were obtained from the immunohistochemistry and the real time 
PCR showed that the MSCs in all of the different cell experiments still 
preserved their stemness after bacterial incubation. To confirm these previous 
results, MSCs in the different cell experiments were directed to the osteogenic 
differentiation lineage. The cells were divided into two major groups. One 
group was osteodifferentiated with the presence of bacteria (O-AA1+, O-
AA100+, O-EC1+, and O-EC100+), while the other was osteodifferentiated 
without the presence of bacteria (O-AA1-, O-AA100-, O-EC1-, O-EC100-, and 
O-control). The osteodifferentiation was confirmed by alkaline phosphatase 
staining, and immunohistochemistry using antibodies against osteopontin. 
Cells in all of the nine different experiments demonstrated positive reactions 
with both of the alkaline phosphatase staining and the immunohistochemistry. 
Further, the degree of osteogenic induction was determined using the real 
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time PCR for the Runx2 and Col1. MSCs in all of the nine different 
experiments showed up-regulation of both the Runx2 and Col1 genes 
confirming the osteodifferentiation.  
Regarding the overall results obtained from this study, it can be stated that 
periodontal pathogenic induction with certain optimum concentrations can be 
used as an enhancing factor that can increase the proliferation and growth 
rates of the MSCs, and can improve and enhance their osteogenic 
differentiation potential at least in vitro.
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